ArticlePDF Available

The Biology of Autoimmune Response in the Scurfy Mice that Lack the CD4Foxp3 Regulatory T-Cells


Abstract and Figures

Due to a mutation in the Foxp3 transcription factor, Scurfy mice lack regulatory T-cells that maintain self-tolerance of the immune system. They develop multi-organ inflammation (MOI) and die around four weeks old. The affected organs are skin, tail, lungs and liver. In humans, endocrine and gastrointestinal inflammation are also observed, hence the disease is termed IPEX (Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. The three week period of fatal MOI offers a useful autoimmune model in which the controls by genetics, T-cell subsets, cytokines, and effector mechanisms could be efficiently investigated. In this report, we will review published work, summarize our recent studies of Scurfy double mutants lacking specific autoimmune-related genes, discuss the cellular and cytokine controls by these genes on MOI, the organ-specificities of the MOI controlled by environments, and the effector mechanisms regulated by specific Th cytokines, including several newly identified control mechanisms for organ-specific autoimmune response.
Content may be subject to copyright.
Biology 2012, 1, 18-42; doi:10.3390/biology1010018
ISSN 2079-7737
The Biology of Autoimmune Response in the Scurfy Mice that
Lack the CD4+Foxp3+ Regulatory T-Cells
Shyr-Te Ju 1,2,3,*, Rahul Sharma 1,2, Felicia Gaskin 4, John T. Kung 5,6 and Shu Man Fu 1,2,3,*
1 Center for Immunity, Inflammation and Regenerative Medicine, School of Medicine,
University of Virginia, Charlottesville, VA 22908, USA
2 Department of Medicine, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA
3 Department of Microbiology, Immunology, and Cancer, School of Medicine, University of Virginia,
Charlottesville, VA 22908, USA
4 Department of Psychiatry and Neurobehavioral Sciences, School of Medicine, University of Virginia,
Charlottesville, VA 22908, USA
5 Academia Sinica, Nankang District, Taipei 11529, Taiwan
6 Department of Immunology, School of Medicine, National Taiwan University, Taipei 10051, Taiwan
* Authors to whom correspondence should be addressed; E-Mails: (S.-T.J.); (S.M.F.).
Received: 2 March 2012; in revised form: 22 March 2012 / Accepted: 26 March 2012 /
Published: 4 April 2012
Abstract: Due to a mutation in the Foxp3 transcription factor, Scurfy mice lack regulatory
T-cells that maintain self-tolerance of the immune system. They develop multi-organ
inflammation (MOI) and die around four weeks old. The affected organs are skin, tail,
lungs and liver. In humans, endocrine and gastrointestinal inflammation are also observed,
hence the disease is termed IPEX (Immunodysregulation, Polyendocrinopathy, Enteropathy,
X-linked) syndrome. The three week period of fatal MOI offers a useful autoimmune
model in which the controls by genetics, T-cell subsets, cytokines, and effector mechanisms
could be efficiently investigated. In this report, we will review published work, summarize
our recent studies of Scurfy double mutants lacking specific autoimmune-related genes,
discuss the cellular and cytokine controls by these genes on MOI, the organ-specificities of
the MOI controlled by environments, and the effector mechanisms regulated by specific
Th cytokines, including several newly identified control mechanisms for organ-specific
autoimmune response.
Biology 2012, 1 19
Keywords: Scurfy mice; regulatory T-cells; multi-organ inflammation; genetic control
of MOI
1. Introduction
Self-tolerance is mediated by the CD4+Foxp3+ regulatory T-cells (Treg) [15]. Treg expression
depends on the X-linked gene encoding the transcription factor Foxp3 [4,5]. Patients bearing a mutation
in their foxp3 gene invariably develop IPEX (immune disregulation, polyendocrinopathy, enteropathy,
X-linked) syndrome, which is characterized by systemic multi-organ inflammation manifested as
diarrhea, eczematous dermatitis, insulin-dependent diabetes mellitus, anemia, thrombocytopenia,
neutropenia, and tubular nephropathy [6]. However, variation of symptoms is observed among families
and within families [6]. The severity of the mutational effect, genetic background that influences
Foxp3 expression or function, environment, and age are likely contributing factors.
The IPEX mutations are rare and often affect different positions of the Foxp3, leading to different
manifestations and severity of the autoimmune responses [6]. In contrast, the mutation in Foxp3 of the
genetic homogeneous Sf mice results in total absence of Treg. Sf mice were originally derived by
W.L. Russell from Oak Ridge National Lab. They were maintained in a non-inbred background [7].
Godfrey et al. had generated a 129/RI (H-2b) congenic background and a C3H/HeSnJ (H-2b) congenic
line to study Sf inflammation [8]. Others have bred the Sf mutant gene into the BALB/c background [9].
Means et al. backcrossed Foxp3sf/+ females to C57BL/6NTac males. The Jackson Lab received N8 mice
and backcrossed to C57BL/6J to generate B6.Sf mice [10]. Because of genetic homogeneity,
spontaneous autoimmune response develops in a rapid, predictable and unabated manner, leading to
severe multi-organ inflammation (MOI), and death around 3 to 4 weeks of age. The major organs
affected among Sf mice of various genetic backgrounds are observed in skin, lungs, liver, and stomach.
Because the large repertoire of mutant gene mice is available in B6 background, B6.Sf mice are the
mutant of choice to study genetic control of Sf MOI. This autoimmune inflammation provides an ideal
and highly efficient model to study the autoimmune regulation controlled by Treg and various
inflammation factors that regulate inflammation beyond the Treg checkpoint.
The skin, tail, lungs and liver are affected first in Sf mice [11]. Sf mice may have the potential to
develop inflammation in other organs. A low frequency of organ-specific T-cells, a limited supply of
antigen (Ag), the pre-weaning condition, organ development and early death are potential reasons that
affect their development. Transfer of Sf T-cells into Rag1/ recipients induced inflammation in
additional organs [11]. Severe gastrointestinal inflammation rapidly developed in neonatal Rag1/
recipients just a few days after weaning, suggesting mother’s milk and the intestinal microbes play a
role in the enteropathy [11]. Moreover, inflammation could be demonstrated in accessory reproductive
organs in Sf.Faslpr/lpr double mutant mice that lived beyond adulthood [12]. Thus, Sf mice offer a
unique system to study how MOI is developed and regulated by various immune response genes and
environmental changes. A frequently used approach is to breed a specific gene, usually in its mutant
form, to Sf mice and then determine its effect on the autoimmune response at the organ, cellular and
molecular levels. Another approach is to prolong the life span of the Sf mice by various means and
study the autoimmune response under different environments.
Biology 2012, 1 20
2. Genetic Control of MOI in Sf Mice
2.1. Lymphocyte Requirement
MOI and early fatality were inhibited when Rag1/ or Rag2/ mutant gene was bred into Sf mice,
demonstrating the critical role of lymphocytes in the fatal autoimmune responses in Sf mice [13].
Under normal conditions, the development of a “mature” immune system is complete by 46 weeks
of age. In addition to genetic factors, the establishment of gut microbiota after weaning contributes to this
transition. The fact that fatal MOI develops in 24 weeks old Sf mice indicates that a complete and
competent autoimmune response system is already in place within 2 weeks of birth and that the normal
maturation of peripheral immune system is constrained by Treg.
2.2. T-Cell Repertoire Requirement
Because the MOI in Sf mice is mediated by polyclonal CD4+ T-cells, T-cell receptor (TCR)
repertoire reduction by genetic manipulation impacts the disease. Breeding foreign Ag-specific TCR
transgenes (Tg) into Sf mice delayed but did not eliminate the fatal MOI [13]. Importantly, TCR Tg Sf
mice in Rag/ background did not develop Sf disease because the polyclonal TCR repertoire was not
generated [13]. In TCR Tg mice, Tg TCR genes greatly reduce but do not completely block endogenous
TCR gene rearrangement. A substantial fraction (~30%) of their T-cells expresses dual-TCR [14,15].
The endogenous TCR repertoire derived is large enough to elicit MOI, although their quantity on a per
cell basis is reduced. These considerations explain the delayed but still fatal MOI in Sf mice bearing
foreign Ag-specific TCR Tg.
The power of Treg control of dual-TCR T-cell expansion was studied in the ovalbumin
(OVA)323-339-Tg TCR in Sf mice [16]. The dual-TCR T-cells were detected at 6 days after birth and
could reach to 85% of the lymphocytes. By contrast, T-cells bearing only Tg TCR were not activated
because OVA323-339 was absent in the mice. The expansion of T-cells bearing non-Tg TCR occurred in
the peripheral lymphoid tissues but not in the thymus. Importantly, transfer of T-cells that had been
depleted of the Tg TCRE into Rag1/ mice induced MOI, suggesting MOI could be induced by
T-cells bearing endogenously derived TCRE [16].
Many mutant genes involved in various forms of autoimmune inflammation have been bred into Sf
mice to study their impact on autoimmune manifestation. We will discuss these studies first. Recently,
we have conducted additional studies on 11 mutant inflammation related genes in Sf double mutant
mice [17,18]. These studies include genome-wide microarray and functional analyses. The findings
and significance of the study will be discussed later.
The Th cells that are supposed to be Treg in Sf mice in fact develop into Th cells with both Th1 and
Th2 subsets. They do not produce IL-2 and are dependent on conventional Th cells for survival. Other
have suggested that these “Treg wannabe” cells are enriched for “autoreactivity [19,20].
2.3. Sf.Cd4/ and Sf.
2m/ Mice
Breeding Cd4/ and
2m/ genes into Sf mice demonstrated that Cd4/ but not
2m/ gene
affected the mortality, organ inflammation, and immunological parameters of Sf mice, thus, implicating
Biology 2012, 1 21
the critical role of CD4+ T-cells to the fatal disease [21]. The lifespan of Sf.Cd4/ mice was extended
from 4 weeks to 7 weeks. However, class-II-restricted T-cells might still have been activated. Their
activation in the Sf.Cd4/ mice was likely delayed by the lack of the CD4 co-receptor signal rather
than lacking class-II-restricted T-cell response. Treatment with anti-CD4 mAb also delayed the MOI
and fatality [21].
2.4. Sf.Cd28/ Mice
CD28 on CD4+ T-cells interacts with B7 on Ag-presenting cells. This interaction provides the
co-stimulation signal required for optimal T-cell activation of CD4+ T-cells. Breeding Cd28/ mutant
gene into Sf mice greatly extended the lifespan of the double mutant mice; 50% of which lived more
than 200 days [22]. The spontaneous T-cell activation is greatly reduced in Sf.Cd28/ mice as reflected
in the presence of a low fraction of CD44+ T-cells and the inability of their T-cells upon activation to
produce high levels of IFN-J, IL-4 and IL-10. Paradoxically, IL-2 production upon activation by anti-
CD3 and anti-CD28 was comparable among B6, Sf and Sf.Cd28/ mice [22]. Serum IgE and IL-4,
which were high in Sf mice, were reduced significantly in Sf.Cd28/ mice. Consistent with the
weakened activation, Sf.Cd28/ mice did not show detectable inflammation in liver and lungs [22].
Surprisingly and unfortunately, the effect of Cd28/ on skin inflammation was not reported and the
perplexing “normal” IL-2 response was not explained [22]. It seems like Sf.Cd28/ mice have a
generally depressed immune response, such that all MOI were reduced and lifespan prolonged.
2.5. K/BxN.Foxp3sf Mice
Kouskoff et al. generated a B6 TCR Tg mouse line designated KRN mice [23]. Their TCR genes
were derived from an RNase-specific B10A.4R T-cell hybridoma. Surprisingly, when KRN mice were
crossed with NOD mice, the progeny, i.e., the KRN Tg TCR in {B6xNOD}F1 mice, developed arthritis
with severe joint inflammation, which depended on the presence of Tg TCR and Ab with specificity to
glucose-6-phosphate isomerase (GPI) [24]. Apparently, a cross-reaction between the Tg TCR and GPI,
processed and presented by the I-Ag7 Ag-presenting cells, initiates the disease process. Negative
selection deleted some Tg TCR T-cells in the thymus. Some Tg TCR T-cells (likely expressing dual-
TCR) could escape the deletion and emerge in the periphery to initiate the disease process [23].
The lifespan of K/BxN.Foxp3sf mice was prolonged as compared with Sf mice. The arthritis
developed faster and was more aggressive as compared with K/BxN mice due to the lack of Treg in the
affected joints and an increased production of anti-GPI Ab [25] but the expansion of GPI-specific
T-cells was also a likely contributing factor. Like other TCR Tg Sf mice, the majority of CD4+ T-cells
in the secondary lymphoid organs are CD44+. These cells could be expanded both by GPI-specific
activation through the Tg TCR or by endogenous TCR of the dual-TCR T-cells [23].
2.6. NOD.Foxp3sf Mice
The NOD.foxp3sf mice developed more severe MOI but their lifespan was not shortened as
compared with B6.Foxp3sf mice [26]. Their diabetic incidence was not reported, probably because the
early death prevented such an analysis [26]. Indeed, the effect of total Treg-deficiency on many
Biology 2012, 1 22
chronic autoimmune diseases may not be easily studied because of the dominant and rapid lethality of
Foxp3sf mutation.
The BDC2.5 TCR Tg specific to an islet Ag was used to generate the BDC2.5/NOD.Foxp3sf mice
to study Treg effect on type-1 diabetes [27]. Both MOI and mortality were ameliorated as compared
with Sf or NOD.Foxp3sf mice. Interestingly, diabetes developed around 2 weeks after birth and
100% incidence was observed at 18 days of age. BDC2.5/NOD.Rag/ mice also lacked Treg and
developed diabetes earlier than BDC2.5/NOD mice [27]. Diabetes developed at 20 days after birth and
100% incidence occurred at 30 days after birth. The T-cells in BDC2.5/NOD.Foxp3sf but not
BDC2.5/NOD.Rag/ mice contain endogenous TCR. The expansion of the dual-TCR T-cells
starts around 6 days after birth in Sf mice [16]. The expansion facilitates dual-TCR T-cell
participation during diabetes development, if the dual-TCR T-cells are enriched in the islets of
BDC2.5/NOD.Foxp3sf mice.
2.7. Sf.Aire/ Mice
The Aire gene is expressed in thymic stromal cells. It controls the synthesis of several tissue-specific
Ag required for the deletion of the Ag-specific autoimmune T-cells during thymic selection [28]. Mice
with mutant Aire genes develop autoimmune diseases directed mostly against endocrine organs [28].
Aire has little influence on Treg expression and function. Sf.Aire/ mice have a gravely shortened
lifespan even though their endocrine organs remained free from inflammation [26].
In these autoimmune models, the Foxp3Sf effect is so dominant that its effect on the specific
autoimmune models is difficult to access. It seems that the effect of Foxp3sf on Aire, NOD, and
BDC2.5.NOD mice is largely due to the absence of Treg rather than due to the interactions of the
responsible autoimmune gene with the Foxp3sf mutation.
2.8. Sf.Il2/ Mice
IL-2 knockout (Il2/) mice develop lymph node (LN) enlargement and inflammation in colon, liver
and salivary glands [12,29]. Il2/ mice are deficient in Treg, although a reduced level was present due
to compensation from IL-7 and IL-15 and this compensation may have prolonged their lifespan longer
than that of Sf mice [30]. The Treg-deficiency may explain the lympho-proliferation and MOI.
However, the MOI in Il2/ mice differs from Sf mice because only the latter develop severe inflammation
in skin and lungs [11]. The phenotype of Il2/ mice is dominant because Sf.Il2/ mice failed to
develop skin and lung inflammation whereas their liver inflammation remained [29]. These results
strongly suggest that MOI in Sf mice is controlled in an apparent “organ-specific” manner by IL-2.
Interestingly, LN of Sf.Il2/ mice are larger and contain more lymphocytes than those in Sf
mice. Apparently, lacking IL-2 did not inhibit T-cell activation and proliferation in vivo. Other
lympho-proliferative cytokines such as IL-4, IL-7, and IL-15 were not higher in Sf.Il2/ sera as
compared with Sf samples [17]. Reduced FasL (CD178) expression has been implicated in the
lymphadenopathy in Il2/ mice but FasL expression in Sf.Il2/ mice was no less than that in Sf
mice [29]. Inhibition of lymphocyte trafficking, either out of LN or into peripheral tissues, or both,
may cause accumulation of lymphocytes in the LN. Our recent genome-wide microarray analyses and
additional breeding studies on the effect of specific mutant genes on MOI have demonstrated new and
Biology 2012, 1 23
heretofore under-appreciated IL-2 functions in the Sf MOI response. This new information will be
addressed later in great detail.
2.9. Sf.Itgae/ Mice
The control of IL-2 on CD4+ T-cell retention in inflamed skin and lungs was demonstrated in Sf and
Sf.Il2/ mice. IntegrinDH (CD103) is a component of a cell surface receptor DEE7 that binds to
E-cadherin expressed mainly by epithelial cells. As a result, T-cells expressing CD103 are retained in
tissues like skin and lungs. In Sf mice, the frequency of CD4+CD103+ T-cells in the LN is significantly
higher than the B6 counterpart [31]. An even higher frequency is observed in the skin and lungs. The
high frequency of CD4+CD103+ T-cells is reduced in Sf.Il2/ mice, demonstrating the requirement of
IL-2 for CD103 expression on CD4+ T-cells. In vitro culture experiments demonstrated that optimal
expression of CD103 also required TGF-E1. IL-2 requirement for CD103 expression is specific for
CD4+ T-cells including Treg. Interestingly, the Treg deficiency in Il2/ mice is observed mainly in the
CD103 Treg [25], suggesting a subtle difference in the regulation of CD103 and Foxp3 expression.
Perhaps the IL-15- or IL-7-induced Treg does not efficiently express CD103. CD103 expression on
CD8+ T-cells between Sf and Sf.Il2/ mice appears comparable as do their dendritic cells [31].
The inflammation in the skin and lungs but not liver in Sf.Itgae/ mice is delayed for a few
weeks, indicating that the IL-2-controlled CD103 expression on CD4+ T-cells contributed to the
“organ-specific” inflammation. However, the lack of CD103 cannot fully explain the complete
inhibition of skin and lung inflammation in Sf.Il2/ mice because Sf.Itgae/ mice eventually develop
a severe skin and lung inflammation comparable to that observed in Sf mice. Thus, IL-2 must control
additional components of the skin and lung inflammatory process [31].
2.10. Sf.Faslpr/lpr Mice
Fas (CD95)/FasL signaling system is known for T-cell homeostasis control but its role in organ
damage is less appreciated. As compared with Sf mice, LN lymphocytes in Sf.Faslpr/lpr mice increased
20% in number whereas 100% increase was seen for Sf.Il2/ mice [29]. The lifespan of Sf.Faslpr/lpr
mice (1214 weeks old) was comparable to Sf.Il2/ mice. In addition to the skin and lungs,
inflammation was extended to other organs. Unlike Sf mice, Sf.Faslpr/lpr and Sf.Il2/ mice developed
inflammation in colon and accessory reproductive organs [12]. These observations suggest that
FasL-dependent organ damage is an important factor for mortality induced by the MOI.
3. Participation of Th Subsets in Sf MOI
Th1, Th2, and Th17 cells are known effectors for autoimmune inflammation. Many inflammation
conditions including IPEX correlated with enhanced Th2 response and IgE expression, but the
contribution by expanded Th1 response was often ignored. The over-emphasis of Th subset imbalance
and the frequent attribution of a single Th subset for inflammation often prevent a better understanding
of autoimmune regulation. For instance, IL-2 is critically important in Th2 cell development under the
Th2 induction condition in vitro [32,33], yet its role in allergic inflammation is often ignored by many
and rarely addressed [34,35]. The Sf.Il2/ mice represent the first animal model in which the role of Th1
Biology 2012, 1 24
cytokine IL-2 in a “Th2-mediated allergic autoimmune inflammation can be explored. Sf mice
displayed highly up-regulated Th1 and Th2 but not Th17 responses. Interestingly, serum IgE, IL-4,
IL-5, and IL-13 and CD4+ T-cells bearing these cytokines were up-regulated in Sf but not in Sf.Il2/
mice as compared with B6 control. This is interesting in light of the fact that the hyper-production of
Th2 cytokines (IL-4, IL-5, and IL-13) and IgE in Sf mice were reduced to normal levels in Sf.Il4/
mice and yet, skin and lung inflammation persists in the latter group [18]. This comparison suggests
that the skin and lung inflammation in Sf mice also involves Th1 responses and that a critical step
shared by both Th1 and Th2 responses for skin and lung inflammation must have been inhibited in
Sf.Il2/ mice.
3.1. How IL-2 Controls Skin and Lung Inflammation?
To address this issue, genes differentially expressed among LN CD4+ T-cells of B6, Sf and Sf.Il2/
mice were determined [17]. A large number of genes encoding receptors for trafficking, chemotaxis, and
retention (altogether abbreviated as the trafficking receptor genes or TRG) were differentially expressed
in Sf samples as compared with Sf.Il2/ samples. Among them, many skin-homing receptors such as
Cysteinyl Leukotriene Receptor 1 (Cysltr1), Leukotriene E4 Receptor 1 (Ltb4r1), CD103, CCR8, and
others are the most differentially expressed [17]. These observations suggest that T-cell entrance into
skin and lungs is a critical step preceding the T-cell activation in these organs and the subsequent
inflammatory response. Consequently, even a strong expansion of potential inflammation-inducing Th
subset in the LN cannot induce skin inflammation when the expression of these trafficking receptors is
inhibited. The chemotactic factors for T-cell entrance to skin and lungs are likely produced by mast
cells, basophils and dermal micro-vessels, melanocytes, and Langerhans cells [36,37]. IL-2, by
regulating the receptors for these ligands and others, enables T-cell infiltration into skin and lungs to
induce clinical symptoms (Figure 1AD).
The most organ-specific autoimmune responses are those mediated by T-cells or Ab that have
specificity against the organ-specific Ag. In Sf mice, anti-keratin-14 Abs against skin and anti-pyruvate
dehydrogenase-E2 against liver/biliary bile duct have been described [38,39]. However, organ
Ag-specific T-cells in Sf mice remain to be established. A selective expansion of organ Ag-specific
T-cells by IL-2 is hard to envision. The second control point is at the level of T-cell trafficking that
dictates the entrance and long stay of the inflammation-inducing T-cells in the target organs. T-cells that
express the receptors for those ligands produced by the target organs and organs that preferentially
express ligands for these receptors can display inflammation in an apparent organ-specific manner. Th
cytokine-controlled TRG expression allows the entry of T-cells into skin and lungs and the CD103
expression enables longer stay of the CD4+ T-cells in the E-cadherin-expressing tissue [17,29].
Similarly, the inflammation in the submandibular gland (SMG) of Sf mice required the production of
chemokines induced by toll-like receptor (TLR) agonists [12]. However, Il2/ mice develop
autoimmune disease, leaving many investigators believing it does not have a “pro-inflammatory”
function. The third mechanism is at the stage of T-cell activation in the target organs such as skin and
lungs that have a propensity to expand Th2 responses and IgE-mediated inflammation.
Biology 2012, 1 25
Figure 1. A schematic representation of how IL-2 controls the skin and lung inflammation
in Sf mice. (A) In the Treg-deficient mice, tissue or environmental Ag are picked up and
processed by the dendritic cells (DC), which go to the draining LN and are presented to the
Th-cells that have specificity for the Ag. Without Treg and in the presence of IL-2, both
Th1 and Th2 responses are expanded. TRG essential for Th cells to go to skin and lungs
are induced in both subsets, which then travel to the skin and lungs to induce inflammation;
(B) In the Sf.Il2−/− mice, the processed Ag on DC failed to induce a Th2 response due to
the absence of IL-2, which is required for Th2 expansion. More importantly, IL-2 is
required for the induction of a panel of TRG required for the Th cells to travel to the skin
and lungs. IL-2 is not required for the induction of TRG needed for liver inflammation and
colitis; (C) In the Sf.Il4−/− mice, the processed Ag on DC induce Th1 response and but the
expression of IL-4-, IL-5-, and IL-13-Th2 cells are not expressed or are strongly inhibited.
We do not know if they were activated by IL-2. However, the TRG required for skin and
lung inflammation are induced in the Th cells by the presence of IL-2. These Th cells are
capable of causing skin and lung inflammation; (D) In the Sf.Ifng−/− mice, the processed
Ag on DC induced both IL-2-producing Th1 cells and IL-4-producing Th2 cells. Although
lacking IFN-J has a general effect (such as recruitment of leukocytes and enhancing
Ag-presentation on inflammation), skin and lung inflammation eventually developed
because the IL-2-controlled TRG are induced in the activated Th1 and Th2 subsets.
Biology 2012, 1 26
Figure 1. Cont.
3.2. Genome-Wide Microarray Comparison among CD4+ T-Cells of Sf and Sf.Il2−/− Mice
To identify the critical targets controlled by IL-2 in the CD4+ T-cells, we compared gene expression
in the FACS-purified LN CD4+ T-cells of Sf and Sf.Il2−/− mice [17]. An RNA sample prepared from
pooled LN CD4+ T-cells of two age-matched B6 male were also included for comparison. A total of 346
probes showed significant difference in expression between Sf and Sf.Il2−/− samples. We eliminated
those that were repetitive for the same gene and the genes whose function is not known to be specifically
related to the immune system. This maneuver resulted in 79 IL-2-regulated genes that may have a role
in the skin and lung inflammation in Sf mice.
3.3. IL-2 Regulates many TRG in the CD4+ T-Cells of Sf Mice
Among the 79 genes, 38 are well known for their participation in the immune activation and/or
inflammatory diseases. Two major differences were observed. First, the over-expression of Cysltr1
(32-fold), Ltb4r1 (9-fold), Il1rl1 (14-fold), Itgae (18-fold), and Ccr1 (8-fold) and to a lesser extent Itga6
(2-fold), Ccr2 (2-fold), Ccr8 (3-fold), and Cxcr6 (3-fold) was observed in Sf over Sf.Il2/ samples.
The second important observation is that there was no major differential expression of Th cytokine
genes involved in inflammation between Sf and Sf.Il2/ samples, although many of these genes were
over-expressed in both samples when compared with B6 control. It is surprising that many of the Th2
Biology 2012, 1 27
cytokine genes were expressed in Sf.Il2/ samples yet these mice lacked skin and lung inflammation.
Nevertheless, this interesting observation further supports the importance of up-regulation of TRG on Th
cells for organ inflammation.
3.4. Sf CD4+ T-Cells that Displayed Differential Gene Expression Selectively Transferred Skin and
Lung Inflammation
To determine whether the organ-specific control of inflammation is an intrinsic property of CD4+ T
cells, inflammation in organs not dependent on IL-2 was demonstrated [29]. The results showed that
CD4+ T-cells of Sf but not Sf.Il2−/− mice induced skin and lung inflammation and the extent of
inflammation difference was highly significant. In contrast, comparable levels of inflammation in the
liver, pancreas, colon, and SMG were observed in both groups. Moreover, the skin and lung
inflammation did not develop throughout the experimental period when the mice became moribund. The
study demonstrated that CD4+ T-cells that expressed a collective set of IL-2-regulated genes can transfer
skin and lung inflammation and that the apparent organ-specificity by IL-2 in Sf mice is an intrinsic
property of the CD4+ T-cells.
3.5. IL-2 Regulates Expression of Inflammatory Cytokines
As observed in the microarray analyses, many of the inflammatory cytokine genes were highly up-
regulated in the CD4+ T-cells of Sf and Sf.Il2−/− mice when compared with B6 CD4+ T-cells. It appears
that the role of IL-2 in regulating Th2 cytokine gene expression is less impressive than its ability to
regulate CD4+ T-cell TRG in Sf mice. However, it has been shown in in vitro experiments that IL-2 is
required for optimal Th2 response [32,33].
To resolve the role of IL-2 in Th cytokine production in vivo, we determined the serum levels of
these cytokines by multiplex cytokine assay even though some of those are also produced by
non-CD4+ T cells, and this measurement represents the cumulative expression of the cytokines [17].
We observed no difference in the expression of TNF-D or IFN-J between Sf and Sf.Il2−/− mice.
Surprisingly, IL-4, IL-5, and IL-13 were significantly lower in the Sf.Il2−/− sera. IL-3 and M-CSF were
also markedly lower in Sf.Il2−/− sera. Serum IL-10 and IL-17 were not significantly different between
Sf and Sf.Il2−/− mice [17].
We also conducted ex vivo stimulation of the CD4+ T-cells from B6, Sf, and Sf.Il2−/− mice to
determine whether the specific Th cytokine-producing cells were differentially regulated during T-cell
activation. The results showed that the frequency of Th2 but not Th1-cells was significantly lower in
Sf.Il2−/− CD4+ T-cells as compared with Sf samples [17].
Our study suggests that IL-2 regulates skin and lung inflammation at two different stages of the
inflammation process. The major targets of IL-2 in Sf mice are those receptors required for CD4+
T-cell trafficking. IL-2 also controls the cumulative levels of Th2 cytokines in Sf mice and the
frequency of Th2 cells during T-cell activation. Our results suggest that the differentially displayed
genes induced by and during T-cell activation play a critical role in this process.
Biology 2012, 1 28
3.6. Restoration of TRG Expression by rIL-2
To determine whether IL-2 can restore TRG expression, we stimulated the FACS-sorted CD4+
T-cells from 15 days old B6 male, Sf, and Sf.Il2−/− mice in the presence of exogenous rIL-2 for 3 days.
Both IL-2 and IL-4 were able to restore the expression of Cysltr1. In this case, IL-2 could have
induced IL-4, which then induced Cysltr1 expression, an indirect pathway that could occur for other
IL-2-regulated genes. A weak trend of increase of Il1rl1 by IL-2 was noted in Sf.Il2−/− samples. This is
similar to the partial restoration of CD103 by IL-2 [29]. The Ltb4r1, Il1rl1, and Ccr1 genes, which
were expressed at lower levels in the Sf.Il2−/− mice, could not be restored to the level in Sf mice by the
3-day stimulation. Because the expression of Itgae was regulated both by TGF-β1 and IL-2, we also
added rTGF-β1 to the culture system along with IL-2. However, the combination was unable to restore
the expression of Ltb4r1, Il1rl1, and Ccr1 on the CD4+ T-cells of Sf.Il2−/− mice. Interestingly, the
expression of Ltb4r1, Il1rl1, and Ccr1 in the CD4+ T-cells from the Sf mice was inhibited when
rTGF-β1 was present. TGF-β1 also inhibited the IL-4 induction of Cysltr1 in the Sf.Il2−/− sample.
Thus, the inability of IL-2 or IL-4 to restore TRG expression in Sf.Il2−/− CD4+ T-cells in vitro is not
due to lack of TGF-β1. This could be the result of an irreversible differentiation of the CD4+ T-cells
due to the repeated in vivo stimulation of the cells in the absence of IL-2. Thus, at least two pathways
are used by IL-2 to regulate TRG expression. Those that can be completely or partially restored by
IL-2 are likely under the direct control of IL-2 signal for gene activation and those that cannot be
immediately restored appear to require additional cell differentiation processes or other cytokines for
their up-regulation in vivo.
3.7. Th1 Response is Dominant and Controlling in Skin and Lung Inflammation in Sf Mice
Th1 response is defined by its ability to produce IL-2 and IFN-J, although IL-2 production is
transient as compared with IFN-J. Our study with Sf.Il2/ mice, therefore, indicates the dominant and
controlling Th1 response to the skin and lung inflammation in Sf mice. Because IL-2 and IFN-J
control different aspects of the inflammatory responses, we compared the autoimmune response
between Sf.Ifng/ with Sf.Il2/ mice.
3.8. MOI in Sf.Ifng−/− Mice
IFN-J is the principal marker for Th1 versus Th2 cells, but NK and CD8+ T-cells also produce high
amounts of IFN-J. As a marker, the absence of IFN-J, particularly in knockout mutant strains such as
Ifng/ or Tbx21/ [40,41], does not mean they lack Th1-cells. IFN-J inhibits Th2 response under the
in vitro induction condition skewed against Th2 development. It activates macrophages, NK cells and
neutrophils, particularly in the presence of LPS, to become potent inflammatory cells. It induces
CXCL9, CXCL10, and CXCL11 from various cells to attract leukocytes to target organs [42,43]. It
induces strong MHC expression and as such exacerbates ongoing immune response. Less is known for
its effect on TRG regulation in CD4+ T-cells. Because both Sf.Il2/ and Sf mice had high serum IFN-J
and IFN-J+ CD4+ T-cells [12], yet only the Sf mice developed inflammation in the skin and lungs, the
question as to what extent the IFN-J influenced the inflammation was addressed.
Biology 2012, 1 29
Breeding Ifng/ mutant gene into Sf mice decreased the cytokine response of CD4+ T-cells that
produced IL-2, TNF-D, IL-4, IL-5, and IL-13. Because a large fraction of IFN-J is produced by NK and
CD8+ T-cells and IFN-J has a very different inflammation-inducing function from IL-2, different
manifestations of inflammation occur. The clinical signs of inflammation in the skin, eyes, ears and tail
were reduced and delayed by 13 weeks. The inflammation in ears, skin, lungs and liver in the 3 weeks
old Sf.Ifng/ mice was still statistically significantly developed when compared with B6 controls. The
lifespan of Sf.Ifng/ mice was prolonged to 67 weeks and the MOI was fully developed at that time.
Surprisingly, the total number of CD3+, CD4+ T-cells and total lymphocytes in the LN (3 weeks old)
were comparable to Sf samples (3 weeks old). The results are in contrast to Sf.Il2/ mice in which the
inflammation in the skin and lungs was inhibited for the entire lifespan even in the presence of
increased IFN-J and expansion of lymphocytes. It is important to note that absence of IFN-J does not
mean the affected response is mediated by Th1 response unless transfer by IFN-J/ Th cells induced
the disease in adoptive transfer experiments.
3.9. Sf.II4−/− and Sf.Stat6−/− Mice Develop Inflammation in the Skin and Lungs
In the Sf.Il4/ and Sf.Stat6/ mice, the clinical signs of skin inflammation and lethargy appear
similar to Sf mice [18]. Histological analysis reveals strong inflammation in the skin, lungs and liver in
these mice even though their Th2 response based on IL-4 production was totally inhibited in Sf.Il4/
mice or greatly reduced in Sf.Stat6/ mice. The total lymphocytes were not different among Sf,
Sf.Il4/ and Sf.Stat6/ mice. In contrast, inflammation in the skin and lungs but not liver was
inhibited in Sf.Il2/ mice even though the total LN lymphocytes were significantly higher than Sf
mice. Thus, IL-4/STAT6-dependent response was not required for the skin and lung inflammation in
Sf mice.
4. Comparison of Cytokine-Producing Profiles of CD4+ T-Cells
4.1. Cytokine-Producing CD4+ T-Cells upon ex vivo Activation
The LN CD4+ T-cells that produced IL-2, IFN-J, TNF-D, IL-10, IL-4, IL-5, IL-13, and IL-17 were
compared among 3-week old B6, Sf, Sf.Il2/, and Sf.Il4/ mice upon ex vivo activation [18]. B6 mice
expressed few IFN-J+CD4+ T-cells, which were increased significantly in Sf mice. In Sf.Il2/ mice,
IL-2+CD4+ T-cells were absent but the frequency of IFN-J+CD4+ T-cells was similar to Sf mice,
indicating that IL-2 deficiency did not affect IFN-J production in Th1 cells.
B6 mice had few IL-4+CD4+, IL-5+CD4+, and IL-13+CD4+ T-cells, which were significantly
increased in Sf mice. The expression of these CD4+ T-cells was strongly inhibited in Sf.Il2/ mice. In
Sf.Il4/ mice, IL-4+CD4+ T-cells were not detected. IL-5+CD4+ T-cells were strongly inhibited, and a
significant but moderate inhibition was observed for IL-13+CD4+ T-cells. The IFN-J+CD4+ T-cells
(~60%) in Sf.Il4/ mice were significantly higher than that in Sf and Sf.Il2/ mice. In addition, this
value was higher than the 30% of IL-2+CD4+ T-cells in the same mice. This could be caused by the
absence of negative regulation of IFN-J production by STAT6 [44]. This increase could compensate
for the reduction of Th2-mediated inflammation in Sf.Il4/ and Sf.Stat6/ mice in the skin and lungs.
By contrast, a significant expression of IL-10+CD4+ T-cells was observed in Sf.Il4/ and Sf.Il2/
Biology 2012, 1 30
samples, suggesting IL-10 expression in Sf CD4+ T-cells is not controlled by IL-2 and IL-4. Similarly,
the frequency of TNF-D+CD4+ T-cells was also increased in Sf mice as compared to B6 control and
the strong expression was not diminished in Sf.Il2/ and Sf.Il4/ samples.
In contrast to Sf.Il4/ mice, IL-4+ Th2 cells were observed in Sf.Stat6/ mice. Although IL-4+ Th2
cells were significantly reduced as compared with Sf samples, they were still significantly higher than
B6 samples [18]. This suggests that IL-2 is more critical than STAT6 in regulating the development
of IL-4+ Th2 cells but STAT6 is still needed for the optimal expansion of the IL-4+CD4+ T-cells in
Sf mice.
Th17 cells are an important effector Th subset in certain autoimmune diseases but how pervasive
and the contribution of this subset to Sf skin and lung inflammation in Sf mice has not been determined.
In Sf mice, despite losing Treg and developing severe MOI, Th17 cells were few as compared with Th1
and Th2 cells [18]. This low value was maintained in all Sf double mutants examined. Th17 cells express
IL-10R and Th17 expansion could be inhibited by IL-10 produced by non-Treg [45]. In summary, the
cytokine expression profiles of Th subsets indicate that IL-2 is the major cytokine critical to the
development of skin and lung inflammation in Sf mice.
4.2. Serum Levels of Cytokines and IgE do not Always Reflect Inflammation Status in the Skin and
Lungs of Sf and Sf Double Mutants
Serum levels of various cytokines (IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IFN-J, and TNF-D)
and IgE of age-matched mice were determined [18]. Sera from Sf mice contained high levels of
cytokines associated with Th1 and Th2 responses. Great variability was observed because some
cytokines were also produced by non-Th cells during inflammation. Low expression of IL-4, IL-5, and
IL-13 was observed in Sf.Il2-/- sera. The only cytokine that was low and not significantly increased
was IL-17 in all samples tested. Our studies suggest that the most influential cytokine for skin and lung
inflammation correlates with serum IL-2. Other cytokines had only partial and fractional effects on
specific aspects of an inflammation response.
The serum IgE level was dramatically increased in Sf mice as compared with B6 sera. It was
inhibited to undetectable levels in the Sf.Il4/ and Sf.Stat6/ mice whereas it remained high in
Sf.Il2/ and Sf.Ifng/ mice. Interestingly, Sf.Il2/ mice expressed a significant serum level of IgE
probably due to IL-4 expression by non-Th2 cells [18]. These data demonstrate that IgE is not essential
for the inflammation in the skin and lungs in the Sf and the Sf double mutant mice examined herein.
5. Th Cytokines Regulate TRG: Mechanism and Specificity
5.1. IL-2 but not IL-4 or IFN-
Regulates TRG for Skin and Lung Inflammtion
IL-2 regulates not only the Th2 response but also TRG in CD4+ T-cells that are capable of
transferring inflammation to the skin and lungs of Rag1/ recipients [12]. Therefore, it becomes
important to determine whether the over-expression of these genes is also restricted to a specific Th
subset or regulated by a specific Th cytokine.
The expression of several TRG in the CD4+ T-cells that had been implicated in the inflammation of
skin and lungs was determined by quantitative PCR [18]. In Sf.Il4/ mice, the marked increase in
Biology 2012, 1 31
Cysltr1, Ltb4r1, and Il1rl1 was not observed in CD4+ T-cells but the inflammation in the skin and
lungs remained. The IL-4-dependent expression of these genes was confirmed with the results from
Sf.Stat6/ samples. The TRG selected for examination were: Cysltr1, Ltb4r1, Ptgir, Il1rl1, Ccr1,
Ccr3, Ccr4, Ccr8, Cxcr3 and Cxcr6, chosen because some of them were selectively increased in Sf
CD4+ T-cells as compared with Sf.Il2/ samples whereas others were enhanced in both samples as
compared with B6 CD4+ T-cells [12]. The expression of Cysltr1, Ltb4r1, and Ptgir were significantly
inhibited in Sf.Stat6/ mice as compared with Sf mice. The expression of Il1rl1 was also reduced, but
was not statistically significant [18]. In contrast, the expression of Ccr1, Ccr3, Ccr4, Ccr8, Cxcr3 and
Cxcr6 remained high in Sf.Stat6/ mice. These observations indicate that the Cysltr1, Ltb4r1, Ptgir,
and perhaps Il1rl1 genes are preferentially regulated by IL-4/STAT6 and that the Th1 cells do not need
their expression to induce inflammation in the skin and lungs in the Sf mice.
Our studies showed that when compared with B6 CD4+ T-cells, Ccr1 and Ccr8 were selectively
enhanced in Sf but not Sf.Il2/ mice whereas Ccr3, Ccr4, Cxcr3 and Cxcr6 were up-regulated in both
mice [12]. The data obtained with Sf.Ifng/ and Sf.Stat6/ mice demonstrated that Cxcr3 expression
among the genes examined was critically dependent on IFN-J [18]. The Sf.Stat6/ mice had the highest
IFN-J and this correlated with the strongest expression of Cxcr3 and Cxcr6 among all samples
examined. Overall, these data demonstrate that inhibiting the TRG regulated by IL-4/STAT6 or IFN-J
is not sufficient to prevent inflammation in the skin and lungs.
Thus, Th responses that control TRG could be summarized as follows. One set of TRG (Cysltr1,
Ltb4r1, Il1rl1, Ptgir and Ccr4) is regulated by IL-2 through the IL-4 produced by Th2 response. These
TRG were inhibited in Sf.Il4/ mice but not inhibited in CD4+ T-cells of the Sf.Ifng/ mice and
would be important in the skin and lung inflammation that develop late in the Sf.Ifng/ mice. The
other set of TRG (Ccr1, Ccr3, Ccr8, Cxcr3 and Cxcr6) are the ones that are independent from the Th2
response and are regulated by the Th1 cytokines. These TRG are responsible for the skin and lung
inflammation in the Sf.Il4/ mice. Because IL-2 is needed for TRG of Th1 and Th2 cells, it has a
more dominant role than Th2 IL-4 in regulating skin and lung inflammation in the Sf mice. A scheme
that summarizes the roles of IL-2, IL-4, and IFN-J in skin and lung inflammation in Sf mice is
presented in Figure 1.
It is important to note that there are up-regulated TRG in Sf, Sf.Il2/, Sf.Ifng/ and Sf.Il4/
Th-cells and these mice displayed liver inflammation and colitis. At present, we have not attempted to
figure out what are the critical TRG for the entrance of the inflammation-inducing Th-cells into liver
and colon.
5.2. Study of Sf.Ltb4r1−/−, Sf.Alox5−/−, Sf.Cx3cr1gfp/gfp and Sf.Il10−/− Mice
This series of studies included Sf double mutant mice from which additional information were
obtained with respect to the effect of cytokines and TRG on Th subset expression and MOI,
respectively [18].
The Sf.Ltb4r1/ mice had expanded Th1 and Th2 responses and inflammation in ears, skin, lungs
and liver. With only 4 mice examined, there was some variability in histological scores for ears, skin
and lungs. Two mice died at 24 days and the other two died at 31 days. On the other hand, Sf.Alox5/
mice displayed severe MOI. Their Th1 cells did not change much but their Th2 cells were twice as many
Biology 2012, 1 32
as that in the Sf mice, and they died within 3 weeks after birth. This could be due to the fact that
5-lipoxygenase produces pro-inflammatory leukotrienes that target Th2 cells, neutrophils, monocytes,
and macrophages [46]. Collectively, the results indicate that leukotrienes and leukotriene receptors could
contribute to but are not as critical as IL-2 to the MOI in Sf mice.
The Cx3cr1 gene encodes Cx3cr1 in lymphocytes, monocytes and macrophages [29]. Its deletion in
Sf.Cx3cr1gfp/gfp mice had no effect on the MOI, consistent with the lack of Cx3cr1 up-regulation in Sf
CD4+ T-cells as compared with B6 samples [12]. The MOI was not inhibited in Sf.Il10/ mice,
indicating that IL-10 had little effect on the Sf autoimmune manifestation, most likely due to the
expression of multiple inflammatory effector mechanisms [12].
In summary, these studies clearly demonstrate that many of the commonly considered elements of
inflammation processes appear unable to influence the spontaneous inflammation in Sf mice. This is
most likely due to the fact that this fatal autoimmune disease has multiple components and pathways
for inflammation and that eliminating a single component is usually non-effective in preventing the
development of inflammation. In this regard, it is not surprising that without Th2 response, IgE, IFN-J,
the skin and lung inflammation still develop due to participating Th1 response. It just happens that
IL-2 is required for the induction of TRG for Th cells trafficking to skin and lungs and we discovered
this new function of IL-2 by comparing Sf and Sf.Il2/ mice and demonstrated that Sf.Il2/ mice lack
these TRG and do not develop skin and lung inflammation.
6. Environmental and Age Effects on MOI
The Sf mice display the most severe form of MOI, but the early death prevents other potential organ
inflammations that may not have had a chance to develop. There are several reasons why inflammation
in these organs develops later than skin, lungs and liver and efforts to understand these reasons from
environment, aging, and organ development will be addressed here.
Skin, lungs, gastrointestinal system, and liver are the first large-size organs exposed to self and
foreign Ag. The skin and lungs are exposed to Ag floating in the air and the skin is further exposed to
areas of contacts such as bedding. Liver and gastrointestinal organs are exposed to food Ag from
mother’s milk. The mother milk contains IgA that would protect against microbiota expansion and
reduce the stimuli in the gastrointestinal tract. These may account for the early and delayed
manifestations of inflammation in these organs.
As discussed earlier, Fas mutation prolongs the lifespan of Sf mice from 4 weeks to 1217 weeks
old and this effect seems to be largely due to FasL-mediated organ damage [12]. Nevertheless, the
delayed death allows the development of new autoimmune inflammation in other organs not
previously observed in Sf mice. Subsequently, other approaches such as that of Sf.Itgae/ mice were
developed that both validated the study of Sf.Faslpr/lpr mice and facilitated a deeper understanding of
environment and age effects on autoimmune response in Sf mice.
Critically speaking, the MOI in Sf mice cannot be considered an autoimmune response without
the identification of the target Ag and their organ-specific association. Perhaps the best example is
the gastritis induced by day-3-thymectomy that activates both T and B cell responses against the
H+/K+-ATPase of stomach parietal cells [47,48]. In experimental autoimmune prostatitis and oocytis,
specific responses against EAPA and MATER organ Ag have been implicated [49,50]. Ab against a
Biology 2012, 1 33
mitochondrial Ag associated with cholangitis has been demonstrated in Sf mice [39]. Because Treg
controls immune responses to both self and foreign Ag, it is possible that the MOI is also contributed
by foreign Ag that are more often associated with a particular organ in the host including the steady
presence of Ag from the environment, food, bedding, microbiota, and growth changes [12,51].
Sf mice die around 2428 days old with severe inflammation in the ear, conjunctiva, skin, lungs,
liver and tail. Common autoimmune diseases such as thyroiditis, diabetes, encephalomyelitis, arthritis,
glomerulonephritis and inflammation in the oral and gastrointestinal tracts are not observed [26,52].
To determine if early death or pre-weaning conditions prevented the expression of inflammation in
these organs, Faslpr/lpr gene was bred into Sf mice to prolong the lifespan to 820 weeks. Using this
approach, additional inflammation was observed in colon and accessory reproductive organs [8]. Thus,
pre-weaning conditions may not be the only factor that affects organ-specific inflammation. Another
method was by transferring Sf LN cells into Rag1/ recipients [52]. This approach not only induced
severe inflammation in the skin, lung and liver but also in salivary gland, stomach, pancreas, small
intestine, and colon, perhaps due to long lifespan and environmental changes. A summary figure
showing the MOI under various conditions was presented in reference11.
6.1. Skin Inflammation
Skin inflammation is the earliest external symptom observed in Sf mice. The severely inflamed
areas are ear, eyelids, and tail. Conjunctivitis is probably worsened by frequent scratching surrounding
the ears and eyes. Adoptive transfer of Sf LN cells into adult Rag1/ recipients induced skin
inflammation first in the eyelids. In contrast, tail inflammation is minimal, suggesting organ
development control of tail inflammation. Sf skin inflammation coincided with a strong Th2 response
and high serum IgE [53] but the Th2 cytokines and IgE expression occurred together with a strong Th1
type response and that strong skin inflammation was observed in Sf.Il4/ mice [18]. In contrast, skin
inflammation in Sf.Il2/ never developed and their LN cells also failed to induce skin inflammation
upon transfer into Rag1/ recipients.
6.2. Inflammation in Salivary and Lacrimal Glands
Sjögren's syndrome is characterized by inflammation in the salivary glands and lacrimal glands
with dry mouth and dry eyes. Il2/ and Il2r
/ mice develop inflammation in these glands and their
ability to produce saliva upon stimulation with Pilocarpine is impaired [54]. Interestingly, Sf mice do
not develop inflammation in these glands but transfer of Sf LN cells into Rag1/ recipients induced
strong inflammation in these organs [54]. The SMG is the major mouse saliva-producing organ and its
development is age-dependent and sexually dimorphic [55]. The acini of the SMG develop soon after
birth and dominate in the early phase of SMG development. The granular convoluted tubules (GCT)
develop around 34 weeks of age and the expression is markedly stronger in male than female.
Infiltration in the salivary glands in Il2/ mice as well as Rag1/ recipients of Sf LN cells was
observed primarily in the areas of acini but also noticeable around the GCT areas, with destruction and
disappearance of the acini and atrophy of GCT [55]. The SMG in Sf mice was not only free from
inflammation but also growth-arrested in that the male-dominant expression of GCT was inhibited,
leaving the organ mostly occupied by the acini. Several observations suggest that GCT development is
Biology 2012, 1 34
not important for SMG inflammation. First, treatment of Sf.Faslpr/lpr mice with testosterone fully
restored GCT development but failed to induce inflammation in the SMG. Second, SMG inflammation
was observed in Il2/ mice that also have a greatly reduced GCT expression (but not as severe as Sf
mice). Third, treatment of Sf mice with daily oral application of LPS or Poly:I/C induced SMG
inflammation in the absence of GCT development [12]. The latter observations suggest that defect in
innate immunity and Ag-presentation may be involved during the development of SMG.
6.3. Lung Inflammation
Similar to skin, lungs are constantly exposed to environmental Ag. Lung inflammation in Sf mice is
characterized by the severe infiltration of leukocytes around the bronchia and alveoli. In contrast, lung
inflammation was not observed in Il2/ mice and Sf.Il2/ mice [29]. A recent study has demonstrated
that lacking IL-10-producing Treg is inductive to skin and colon inflammation [56]. However, a
normal level of IL-10 mRNA expression was observed in the Treg of Il2/ mice [57].
In contrast to Il2/ mice, Il2r
/ mice display severe lung inflammation. Il2r
/ mice differ from
Il2/ mice in that they over-express CD8+ memory T-cells that occupy more than 75% of the total
T-cell repertoire. As a result of lacking high affinity IL-2R, Il2r
/ mice accumulated high serum levels
of IL-2 which could stimulate through the low-affinity IL-2R on CD8+ T-cells (un-stimulated CD4+
T-cells express few low-affinity IL-2R) [58]. It is tempting to speculate that these CD8+ T cells are
responding to air and environmental Ag such as virus that are presented through class-I Ag processing
pathway by the lung Ag-presenting cells.
6.4. Gastritis and Small Intestine Inflammation
Gastritis and small intestine inflammation are neither observed in Sf mice nor in the Sf.Faslpr/lpr
mice that have a prolonged lifespan beyond weaning. However, they were induced by transfer of Sf
LN cells into Rag1/ recipients [52]. Moreover, gastritis and small intestine inflammation were not
observed in Il2/ mice and transfer of Sf.Il2/ LN cells failed to induce inflammation in the organs.
Thus, adoptive transfer of LN cells from Sf and Sf.Faslpr/lpr mice into Rag1/ recipients remains the
only protocol capable of inducing gastritis and small intestine inflammation. Although we observed
inflammation around the areas containing the parietal cells, whether this inflammation includes a
component against H+/K+ ATPase, like the case in the BALB/c mice thymectomized at 3 days after
birth, is unknown at present.
6.5. Liver Inflammation and Cholangitis
Both Il2/ and Sf mice develop liver inflammation manifested by peri-vascular infiltration of
leukocytes. High titers of Ab against pyruvate dehydrogenase complex component E2 characteristically
associated with cholangitis were identified in the sera of Sf mice [52]. Leukocyte infiltration was
observed around portal areas with damage in the biliary duct. Livers from Sf mice strongly expressed
inflammatory cytokines including TNF-D, IFN-J, IL-6, IL-12 and IL-23 [52]. Presence of anti-E2 Ab
was also detected in Il2/ and Sf.Il2/ mice. Autoimmune cholangitis was observed in Il2R
/ mice and
Biology 2012, 1 35
it was shown that this autoimmune disease is, in contrast to colitis, more dependent on the expression of
CD8+ T-cells [58,59].
6.6. Pancreatitis
Although often associated with IPEX patients [60], Type-1 diabetes was neither observed in Sf
mice nor in Rag1/ recipients of Sf LN cells. Sf, Sf.Faslpr/lpr, Sf.Il2/ or adult Rag1/ recipients of Sf
LN cells developed very mild pancreatitis with peri-vascular infiltration of leukocytes and occasional
destruction of acini outside the islets. Interestingly, moderate to severe pancreatitis with strong
leukocyte infiltration and severe destruction of acini was observed when Sf LN cells were transferred
IP into neonatal or adult Rag1/ recipients [52]. Using Sf.OT-II mice, we showed that in the absence
of Treg, Ag-reactive T-cells still required the Ag in order to expand, i.e., OT-II clonotypic T-cells were
not expanded due to the absence of OVA whereas dual TCR T-cells were expanded by the host
Ag [16]. Thus, Treg-deficiency plays more of a facilitating role in the disease process. As type-1
diabetes is often observed in IPEX patients, this study suggests that the IPEX patients must have
naturally occurring auto-reactive T-cells with sufficient binding activity against the islet components
present in their system.
6.7. Colitis
Sf mice do not develop colitis and this is likely due to the weaning condition because Sf.Faslpr/lpr
mice that lived longer than 4 weeks begin to develop colitis. Moreover, transfer of Sf LN cells into
adult Rag1/ recipients also induced colitis. Transfer into neonate Rag1/ recipients induced little
inflammation in the colon before weaning but severe colitis rapidly developed afterward [52]. Il2/
mice also develop colitis but only after weaning. It is likely that the microbiota present in the colon
contributes to the colitis development. Colon seems to have the easiest millieu for inflammation
induced by adoptive transfer of effector T-cells. Even T-cells expressing a single transduced TCR
often induce colitis and this system has been used to address the auto-reactive repertoire of Treg [61].
It is not clear why such T-cells often selectively induce colitis but not inflammation in other organs,
had they had specificity against a self Ag. The possibility that these TCR recognize food antigens and
colon microbiota has been raised [62]. Moreover, the constant activation of cells of innate immunity
and the high local levels of type-I interferon and IL-1E may be contributors as well.
Integrin DE(CD103)β7 is a critical homing and retention receptor for lymphocytes traveling to and
lodging in E-cadherin-expressing organs., But CD103CD45RBhigh cells have been shown to induce
colitis upon transfer [63]. We generated Sf.Itgae/ mice and they had a prolonged lifespan of 78 weeks
old. They developed colitis and their LN cells were able to transfer colitis to Rag1/ recipients,
demonstrating the presence of a CD103-independent mechanism for colitis [31].
6.8. Myositis
Sf mice do not develop inflammation in the skeletal muscle but direct injection of Sf LN cells into the
limb muscle of Rag1/ mice induces inflammation not only in the injected sites but also in the skeletal
muscle of the other limbs [52]. In contrast, intravenous transfer of Sf LN cells failed to induce skeletal
Biology 2012, 1 36
muscle inflammation. It is possible that directly injected T-cells first induced damage of muscle cells and
the released Ag were recognized by the specific T-cells present in the LN cells and expanded. How
these T cells travel through the circulation to induce inflammation in other limb muscle remains to be
6.9. Inflammation in the Accessory Reproductive Organs
Although Sf.Faslpr/lpr mice have a prolonged lifespan beyond the adult age, they remain
reproductively incompetent with low body weight and under-developed reproductive organs. Gross
examination revealed a tremendous atrophy in the coagulation glands/seminal vesicle, preputial
glands, epididymis and prostate. Histological examination confirmed the atrophy of these organs,
displayed as shrunken glands and empty lumens. This was accompanied by a prominent presence of
leukocyte infiltrates in the peri-glandular regions, in the interstitial regions of the testis, and in the
regions containing the interstitial Leydig cells between the seminiferous tubules. Testosterone treatment
successfully restored the growth of the accessory reproductive organs of Sf.Faslpr/lpr mice but the
leukocyte infiltrates in the reproductive organs were still present [14].
By breeding and adoptive transfer experiments under various experimental conditions, Sf mice are
shown to contain a large repertoire of T-cells capable of inducing inflammation in a large number of
organs and tissues. Polyclonal Treg can suppress the MOI, suggesting the presence of a large repertoire
of functional Treg as well [52]. An important issue is to determine whether inflammation in individual
organs is organ-specific and what they are specific to. In this regard, Sf mice should be useful to
identify organ-specific autoimmune T-cells and their Treg counterparts, although this remains a
daunting task.
7. Conclusions
As a result of the Foxp3 mutation and absence of functional Treg, Sf mice develop fatal MOI within
28 days after birth. This rapid MOI and experimental manipulations can be exploited to further explore
the mechanisms, specificities, and consequences of the MOI. We discussed the biology of Sf MOI from
the points of views of genetic, cellular, cytokine, molecular, environment, and age aspects. Table 1
summarizes all the available information from Sf double mutant mice available from the literature and
our own studies. Amongst these studies, the most surprising and important finding is the discovery of the
previously unrecognized novel role of IL-2 in the expansion of TRG in Th1 and Th2 cells and Th2
cytokine production. Both TRG expression and Th2 response are involved in the skin and lung
inflammation in Sf mice. In addition, the mechanisms and consequences of some of the affected genes
were addressed. While the study of Sf mice can be efficient in order to understand the biology of MOI,
we believe that the genetic control of MOI is similar to cancer in that without correcting the genetic
defect, the disease cannot be easily cured. This is the major reason why in our series of studies various
factors that are well known for participation in skin and lung inflammation such as IgE, Th2 cytokines,
and IFN-J either cannot inhibit or delay the inflammation. It appears that the genetic defect for
inflammation needs a genetic correction for curing the disease.
Biology 2012, 1 37
Table 1. Changes of lymphocyte subsets, MOI, and lifespan of various Sf double mutant mice.
Gene examined
Change in lymphocytes
Sf [21]
Th1 and Th2 subset expansion
34 wk
Sf.TgTCR.Rag−/− [13]
TCR Tg T-cells only
>20 wk
Sf.Cd4−/− [21]
No CD4+ T-cells
6 wk
Sf.β2m−/− [21]
No CD8+ T-cells
4 wk
Sf.TCR Tg [13]
T-cells reduced, dual-TCR
T-cells expanded
7 wk
Sf.NOD [26]
N.D. *
Sf.BDC2.5 Tg TCR in
Lympho-proliferation was
, MOI was not
N.D. **
Sf.Aire−/− [28]
23 wk
Sf.Cd28−/− [22]
Inhibit T-cell activation and
cytokine production
50% lived
>30 wk
mice (Balb/c) [53]
Inhibit IgE and Th2 cytokine
5 wk
Sf.Faslpr/lpr [12,29]
Slight increase in lymphocytes
in LN
, developed
618 wk
Sf.Itgαε−/− [31]
Lymphocyte number decreased
by ~40%
67 wk
Sf.Il2−/− [29]
Lymphocytes in LN increased
100%. CD103 and trafficking
receptors inhibited
, liver
610 wk
Sf.Il4−/− [18]
IL-4, IL-5, and IL-13 CD4+
cells were inhibited. TRG
controlled by IL
-4 were
inhibited. IgE expression was
4 wk
Sf.Stat6−/− (B6) [18]
Reduced IL-4, IL-5 and IL-13
+ T-
cell expression. TRG
controlled by Stat6 were
inhibited. IgE expression was
inhibited. TRG controlled by
IL-2 were not affected
4 wk
Sf.Ifng−/− [18]
Lymphocyte expansion delayed
but fully restored later.
producing Th1 cells were
normal. IL
regulated TRG
were not affected
58 wk
Biology 2012, 1 38
Table 1. Cont.
Gene examined
Change in lymphocytes
Sf.Ltb4r1−/− [18]
Expanded Th1 and Th2
45 wk
Sf.Alox5−/− [18]
Th1 response remained high
and Th2 response was further
3 wk
Sf.Il10−/− [18]
Th1 and Th2 remained high
34 wk
Sf.Cx3cr1gfp/gfp [18]
Th1 and Th2 remained high
34 wk
* Not described; ** TCR Tg should have prolonged the lifespan.
Competing Interests
The authors declare that they have no competing interests.
This work is supported in part by NIH grants AR-051203 (STJ), DE-017579 (STJ), AR-045222
(SMF), AR-047988 (SMF), AR-049449 (SMF) and NSC grants 98-3112-B-001-011 and 98-3112-B-
001-018 (JTK), and Academia Sinica grants 91IMB1PP and 91IMB6PP (JTK).
1. Sakaguchi, S.; Yamaguchi, T.; Nomura, T.; Ono, M. Regulatory T cells and immune tolerance.
Cell 2008, 133, 775787.
2. Shevach, E.M.; DiPaolo, R.A.; Andersson, J.; Zhao, D.M.; Stephens, G.L.; Thornton, A.M. The
lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol. Rev. 2006, 212,
3. Zheng, Y.; Rudensky, A.Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007,
8, 457462.
4. Brunkow, M.E.; Jeffery, E.W.; Hjerrild, K.A.; Paeper, B.; Clark, L.B.; Yasayko, S.A.;
Wilkinson, J.E.; Galas, D.; Ziegler, S.F.; Ramsdell, F. Disruption of a new forkhead/winged-helix
protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet.
2001, 27, 6873.
5. Wildin, R.S.; Ramsdell, F.; Peake, J.; Faravelli, F.; Casanova, J.; Buist, N.; Levy-Lahad, E.;
Mazzella, M.; Goulet, O.; Perroni, L.; et al. X-linked neonatal diabetes mellitus, enteropathy and
endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27, 1820.
6. Wildin, R.S.; Smyk-Pearson, S.; Filipovich, A.H. Clinical and molecular features of the
immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. J. Med.
Genet. 2002, 39, 537545.
7. Godfrey, V.L.; Wilkinson, J.E.; Rinchik, E.M.; Russell, L.B. Fatal lymphoreticular disease in the
scurfy (sf) mouse requires T cells that mature in a Sf thymic environment: Potential model for
thymic education. Proc. Natl. Acad. Sci. USA 1991, 88, 55285532.
Biology 2012, 1 39
8. Godfrey, V.L.; Rouse, B.T.; Wilkinson, J.E. Transplantation of T cell-mediated, lymphoreticular
disease from the scurfy (sf) mouse. Am. J. Pathol. 1994, 145, 281286.
9. Chang, X.; Gao, J.X.; Jiang, Q.; Wen, J.; Seifers, N.; Su, L.; Godfrey, V.L.; Zuo, T.; Zheng, P.;
Liu, Y. The scurfy mutation of foxp3 in the thymus stroma leads to defective thymopoiesis.
J. Exp. Med. 2005, 202, 11411151.
10. Means, G.D.; Toy, D.Y.; Baum, P.R.; Derry, J.M. A transcript map of a 2-Mb BAC contig in the
proximal portion of the mouse x chromosome and regional mapping of the scurfy mutation.
Genomics 2000, 65, 213223.
11. Sharma, R.; Sung, S.-S.J.; Fu, S.M.; Ju, S.-T. Regulation of multi-organ inflammation in the
regulatory T cell-deficient scurfy mice. J. Biomed. Sci. 2009, 16, doi:10.1186/1423-0127-16-20.
12. Sharma, R.; Deshmukh, U.S.; Zheng, L.; Fu, S.M.; Ju, S.-T. X-linked Foxp3 (scurfy) mutation
dominantly inhibits submandibular gland development and inflammation respectively through
adaptive and innate immune mechanisms. J. Immunol. 2009, 183, 32123218.
13. Zahorsky-Reeves, J.L.; Wilkinson, J.E. The murine mutation scurfy (sf) results in an
antigen-dependent lymphoproliferative disease with altered T cell sensitivity. Eur. J. Immunol.
2001, 31, 196204.
14. Heath, W.R.; Carbone, F.R.; Bertolino, P.; Kelly, J.; Cose, S.; Miller, J.F.A.P. Expression of two
T cell receptor α chains on the surface of normal murine T cells. Eur. J. Immunol. 1995, 25,
15. Padovan, E.; Giachino, C.; Cella, M.; Valitutti, S.; Acuto, O.; Lanzavecchia, A. Normal T
lymphocytes can express two different T cell receptor β chains: Implications for the mechanism of
allelic exclusion. J. Exp. Med. 1995, 181, 15871591.
16. Sharma, R.; Ju, A.C.-Y.; Kung, J.T.; Fu, S.M.; Ju, S.-T. Rapid and selective expansion of
nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy
mice: Antigen-dependent expansion and TCR analysis. J. Immunol. 2008, 181, 69346941.
17. Sharma, R.; Sharma, P.R.; Kim, Y.C.; Leitinger, N.; Lee, J.K.; Fu, S.M.; Ju, S.-T. Il-2-controlled
expression of multiple -T cell trafficking genes and th2 cytokines in the regulatory T cell-deficient
scurfy mice: Implication to multiorgan inflammation and control of skin and lung inflammation.
J. Immunol. 2011, 186, 12681278.
18. Sharma, R.; Sung, S.-S.J.; Gaskin, F.; Fu, S.M.; Ju, S.-T. A novel function of IL-2: Chemokine/
chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.
J. Autoimmun. 2012, doi;10.1016/j.jaut.2012.02.001
19. Lahl, K.; Mayer, C.T.; Bopp, T.; Huehn, J.; Loddenkemper, C.; Eberl, G.; Wirnsberger, G.; Dornmair,
K.; Geffers, R.; Schmitt, E.; et al. Nonfunctional regulatory T cells and defective control of Th2
cytokine production in natural scurfy mutant mice. J. Immunol. 2009, 183, 56625672.
20. Kuczma, M.; Podolsky, R.; Garge, N.; Daniely, D.; Pacholczyk, R.; Ignatowicz, L.; Kraj, P.
Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute
a unique cell subset. J. Immunol. 2009, 183, 37313741.
21. Blair, P.J.; Bultman, S.J.; Haas, J.C.; Rouse, B.T.; Wilkinson, J.E.; Godfrey, V.L. CD4+CD8
T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 1994,
153, 37643774.
Biology 2012, 1 40
22. Singh, N.; Chandler, P.R.; Seki, Y.; Baban, B.; Takezaki, M.; Kahler, D.J.; Munn, D.H.;
Larsen, C.P.; Mellor, A.L.; Iwashima, M. Role of CD28 in fatal autoimmune disorder in scurfy
mice. Blood 2007, 110, 11991206.
23. Kouskoff, V.; Korganow, A.S.; Duchatelle, V.; Degott, C.; Benoist, C.; Mathis, D. Organ-specific
disease provoked by systemic autoimmunity. Cell 1996, 87, 811822.
24. Matsumoto, I.; Staub, A.; Benoist, C.; Mathis, D. Arthritis provoked by linked T and B cell
recognition of a glycolytic enzyme. Science 1999, 286, 17321735.
25. Nguyen, L.T.; Jacobs, J.; Mathis, D.; Benoist, C. Where Foxp3-dependent regulatory T cells
impinge on the development of inflammatory arthritis. Arthritis Rheum. 2007, 56, 509520.
26. Chen, Z.; Benoist, C.; Mathis, D. How defects in central tolerance impinge on a deficiency in
regulatory T cells. Proc. Natl. Acad. Sci. USA 2005, 102, 1473514740.
27. Chen, Z.; Herman, A.E.; Matos, M.; Mathis, D.; Benoist, C. Where CD4+CD25+ treg cells
impinge on autoimmune diabetes. J. Exp. Med. 2005, 202, 13871397.
28. Villaseñor, J.; Benoist, C.; Mathis, D. AIRE and APECED: Molecular insights into an
autoimmune disease. Immunol. Rev. 2005, 204, 156164.
29. Zheng, L.; Sharma, R.; Gaskin, F.; Fu, S.M.; Ju, S.-T. A novel role of IL-2 in organ-specific
autoimmune inflammation beyond regulatory T cell check-point: Both IL-2 knockout and fas
mutation prolong lifespan of scurfy mice but by different mechanisms. J. Immunol. 2007, 179,
30. Vang, K.B.; Yang, J.; Mahmud, S.A.; Burchill, M.A.; Vegoe, A.L.; Farrar, M.A. IL-2, -7 and -15,
but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell
development. J. Immunol. 2008, 181, 32853290.
31. Sharma, R.; Sung, S.-S.J.; Abaya, C.E.; Ju, A.C.-Y.; Fu, S.M.; Ju, S.-T. IL-2 regulates CD103
expression on CD4+ T cells in scurfy mice that display both CD103-dependent and independent
inflammation. J. Immunol. 2009, 183, 10651073.
32. Yamane, H.; Zhu, J.; Paul, W.E. Independent roles for IL-2 and GATA-3 in stimulating naïve
CD4+ T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 2005, 202, 793804.
33. Cote-Sierra, J.; Foucras, G.; Guo, L.; Chiodetti, L.; Young, H.A.; Hu-Li, J.; Zhu, J.; Paul, W.E.
Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 2004, 101,
34. Hansen, G.; Berry, G.; DeKruyff, R.H.; Umetsu, D.T. Allergen-specific Th1 cells fail to
counterbalance Th2 Cell-induced airway hyperreactivity but cause severe airway inflammation.
J. Clin. Invest. 1999, 103, 175183.
35. Randolph, D.A.; Stephens, R.; Carruthers, C.J.; Chaplin, D.D. Cooperation between Th1 and Th2
cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 1999, 104, 10211029.
36. Medoff, B.D.; Thomas, S.Y.; Luster, A.D. T cell trafficking in allergic asthma: The ins and outs.
Annu. Rev. Immunol. 2008, 26, 205232.
37. Schaerli, P.; Ebert, L.; Willimann, K.; Blaser, A.; Roos, R.S.; Loetscher, P.; Moser, B.
A skin-selective homing mechanism for human immune surveillance T cells. J. Exp. Med. 2004,
199, 12651275.
38. Huter, E.N.; Natarajan, K.; Torgerson, T.R.; Glass, D.D.; Shevach, E.M. Autoantibodies in scurfy
mice and IPEX patients recognize keratin 14. J. Invest. Dermatol. 2010, 130, 13911399.
Biology 2012, 1 41
39. Zhang, W.; Sharma, R.; Ju, S.-T.; He, X.S.; Tao, Y.; Tsuneyama, K.; Tian, Z.; Lian, Z.X.;
Fu, S.M.; Gershwin, M.E. Deficiency in regulatory T cells results in development of
antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009, 49, 545552.
40. Szabo, S.J.; Sullivan, B.M.; Stemmann, C.; Satoskar, A.R.; Sleckman, B.P.; Glimcher, L.H.
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and
CD8 T cells. Science 2002, 295, 338342.
41. Huang, S.; Hendriks, W.; Althage, A.; Hemmi, S.; Bluethmann, H.; Kamijo, R.; Vilcek, J.;
Zinkernagel, R.M.; Aguet, M. Immune response in mice that lack the interferon-gamma receptor.
Science 1993, 259, 17421745.
42. Mach, F.; Sauty, A.; Iarossi, A.S.; Sukhova, G.K.; Neote, K.; Libby, P.; Luster, A.D. Differential
expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.
J. Clin. Invest. 1999, 104, 10411050.
43. Cole, K.E.; Strick, C.A.; Paradis, T.J.; Ogborne, K.T.; Loetscher, M.; Gladue, R.P.; Lin, W.;
Boyd, J.G.; Moser, B.; Wood, D.E.; et al. Interferon-inducible T cell alpha chemoattractant
(I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through
selective high affinity binding to CXCR3. J. Exp. Med. 1998, 187, 20092021.
44. Metwali, A.; Blum, A.; Elliott, D.E.; Weinstock, J.V. Interleukin-4 receptor D chain and STAT6
signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome
granulomas. Infect. Immun. 2002, 70, 56515658.
45. Huber, S.; Gagliani, N.; Esplugues, E.; O’Connor, W., Jr.; Huber, F.J.; Chaudhry, A.; Kamanaka,
M.; Kobayashi, Y.; Booth, C.J.; Rudensky, A.Y.; et al. Th17 cells express interleukin-10 receptor
and are controlled by Foxp3- and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent
manner. Immunity 2011, 34, 554565.
46. Duroudier, N.P.; Tulah, A.S.; Sayers, I. Leukotriene pathway genetics and pharmacogenetics in
allergy. Allergy 2009, 64, 823839.
47. Suri-Payer, E.; Kehn, P.J.; Cheever, A.W.; Shevach, E.M. Pathogenesis of post-thymectomy
autoimmune gastritis. Identification of Anti-H/K adenosine triphosphatase-reactive T cells.
J. Immunol. 1996, 157, 17991805.
48. Fukuma, K.; Sakaguchi, S.; Kuribayashi, K.; Chen, W.-L.; Morishita, R.; Sekita, K.; Uchino, H.;
Masuda, T. Immunologic and clinical studies on murine experimental autoimmune gastritis
induced by neonatal thymectomy. Gastroenterology 1988, 94, 274283.
49. Setiady, Y.Y.; Ohno, K.; Samy, E.T.; Bagavant, H.; Qiao, H.; Sharp, C.; She, J.X.; Tung, K.S.K.
Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+CD25+
regulatory T cells. Blood 2006, 107, 10561062.
50. Alard, P.; Thompson, C.; Agersborg, S.S.; Thatte, J.; Setiady, Y.; Samy, E.; Tung, K.S.K.
Endogenous öocyte antigens are required for rapid induction and progression of autoimmune
ovarian disease following day-3 thymectomy. J. Immunol. 2001, 166, 43634369.
51. Wen, L.; Ley, R.E.; Volchkov, P.Y.; Stranges, P.B.; Avanesyan, L.; Stonebraker, A.C.; Hu, C.;
Wong, F.S.; Szot, G.L.; Bluestone, J.A.; Gordon, J.I.; Chervonsky, A.V. Innate immunity and
intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455, 11091113.
Biology 2012, 1 42
52. Sharma, R.; Jarjour, W.N.; Zheng, L.; Gaskin, F.; Fu, S.M.; Ju, S.-T. Large functional repertoire
of regulatory T-cell suppressible autoimmune T cells in scurfy mice. J. Autoimmun. 2007, 29,
53. Lin, W.; Truong, N.; Grossman, W.J.; Haribhai, D.; Williams, C.B.; Wang, J.; Martín, M.G.;
Chatila, T.A. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice.
J. Allergy Clin. Immunol. 2005, 116, 11061115.
54. Sharma, R.; Zheng, L.; Guo, X.; Fu, S.M.; Ju, S.-T.; Jarjour, W.N. Novel animal models for
Sjögrens syndrome: Expression and transfer of salivary gland dysfunction from regulatory T
cell-deficient mice. J. Autoimmun. 2006, 27, 289296.
55. Sawada, K.; Noumura, T. Effects of castration and sex steroids on sexually dimorphic
development of the mouse submandibular gland. Acta Anat. (Basel) 1991, 140, 97103.
56. Rubtsov, Y.P.; Rasmussen, J.P.; Chi, E.Y.; Fontenot, J.; Castelli, L.; Ye, X.; Treuting, P.;
Siewe, L.; Roers, A.; Henderson, W.R., Jr.; et al. Regulatory T cell-derived interleukin-10 limits
inflammation at environmental interfaces. Immunity 2008, 28, 546558.
57. Fontenot, J.D.; Rasmussen, J.P.; Gavin, M.A.; Rudensky, A.Y. A function for interleukin 2 in
Foxp3-expressing regulatory T cells. Nat. Immunol. 2005, 6, 11421151.
58. Sharma, R.; Zheng, L.; Deshmukh, U.S.; Jarjour, W.N.; Sung, S.-S.J.; Fu, S.M.; Ju, S.-T. Cutting
edge: A regulatory T cell-dependent novel function of CD25 (IL-2RD) controlling memory CD8+
T cell homeostasis. J. Immunol. 2007, 178, 12511255.
59. Hsu, W.; Zhang, W.; Tsuneyama, K.; Moritoki, Y.; Ridgway, W.M.; Ansari, A.A.; Coppel, R.L.;
Lian, Z.X.; Mackay, I.; Gershwin, M.E. Differential mechanisms in the pathogenesis of
autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(/) mice.
Hepatology 2009, 49, 133140.
60. Bennett, C.L.; Christie, J.; Ramsdell, F.; Brunkow, M.E.; Ferguson, P.J.; Whitesell, L.;
Kelly, T.E.; Saulsbury, F.T.; Chance, P.F.; Ochs, H.D. The immune dysregulation,
polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) is caused by mutations of FOXP3.
Nat. Genet. 2001, 27, 2021.
61. Hsieh, C.S.; Liang, Y.; Tyznik, A.J.; Self, S.G.; Liggitt, D.; Rudensky, A.Y. Recognition of the
peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004, 21, 267277.
62. Pacholczyk, R.; Kern, J.; Singh, N.; Iwashima, M.; Kraj, P.; Ignatowicz, L. Nonself-antigens are
the cognate specificities of Foxp3+ regulatory T cells. Immunity 2007, 27, 493504
63. Annacker, O.; Coombes, J.L.; Malmsgtrom, V.; Uhlig, H.H.; Bourne, T.; Johansson-Lindbom, B.;
Agace, W.W.; Parker, C.M.; Powrie, F. Essential role for CD103 in the T cell-mediated regulation
of experimental colitis. J. Exp. Med. 2005, 202, 10511061.
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
... The scurfy mice and the IPEX patients illustrate variable autoimmune disorders. IPEX patients can suffer from type 1 diabetes mellitus and thyroid disease, increased IgE levels, asthma and food allergies, while dermatitis and increased IgE levels are also present in the scurfy mice (63,(65)(66)(67). A lack of functional Tregs is a common feature in Malt1-KO mice, scurfy mice and IPEX patients (44,46,50,51,(68)(69)(70). ...
... Moreover, a scurfy-like phenotype was described for mice (Malt1 FL/FL Foxp3-cre Tg/+ ) with a specific deletion of Malt1 in Tregs (36,49). However, while Malt1-KO mice as well as MALT1 CID patients display impaired T cell activation (3,22,(38)(39)(40)(41)(42)(43)(44)(45)(46)(47), this is not the case for IPEX patients, scurfy mice and mice only lacking Malt1 in Tregs, where there is a failure to control T cell activation due to the absence of Tregs or the reduced functionality of Tregs leading to lymphoproliferation and autoimmunity, resulting in death (36,49,63,(65)(66)(67)71). ...
Full-text available
MALT1 plays an important role in innate and adaptive immune signaling by acting as a scaffold protein that mediates NF-κB signaling. In addition, MALT1 is a cysteine protease that further fine tunes proinflammatory signaling by cleaving specific substrates. Deregulated MALT1 activity has been associated with immunodeficiency, autoimmunity, and cancer in mice and humans. Genetically engineered mice expressing catalytically inactive MALT1, still exerting its scaffold function, were previously shown to spontaneously develop autoimmunity due to a decrease in Tregs associated with increased effector T cell activation. In contrast, complete absence of MALT1 does not lead to autoimmunity, which has been explained by the impaired effector T cell activation due to the absence of MALT1-mediated signaling. However, here we report that MALT1-deficient mice develop atopic-like dermatitis upon aging, which is preceded by Th2 skewing, an increase in serum IgE, and a decrease in Treg frequency and surface expression of the Treg functionality marker CTLA-4.
... We found neither lymphocytic infiltrates nor positive staining for IgG in the brain of sf mice, indicating an intact BBB. These findings were unexpected since polyclonal effector T cells (both Th1 and Th2 subsets) extensively invade numerous organs in these mice (Sharma et al., 2009), resulting in a strong autoimmune reaction and early death (Ju et al., 2012;Singh et al., 2007;Zahorsky-Reeves and Wilkinson, 2001). Only activated and not naïve T cells are able to disrupt BBB integrity, invade the CNS, and induce an inflammatory cascade (Lindner et al., 2018;Schlager et al., 2016). ...
Regulatory T cells (Treg) maintain immunological self-tolerance and their functional or numerical deficits are associated with progression of several neurological diseases. We examined the effects of Treg absence on the structure and integrity of the unchallenged murine brain. When compared to control, Treg-deficient FoxP3sf mutant mice showed no differences in brain size, myelin amount and oligodendrocyte numbers. FoxP3sf strain displayed no variations in quantity of neurons and astrocytes, whereas microglia numbers were slightly reduced. We demonstrate lack of neuroinflammation and parenchymal responses in the brains of Treg-deficient mice, suggesting a minor Treg role in absence of blood-brain barrier breakdown.
... Many cytokines are implicated in the development of lethal inflammation induced by Treg deficiency [21]. To understand which cytokines were involved in the inhibition by antibiotics of lethal inflammation in SF mice, we assessed plasma level of several cytokines. ...
Full-text available
Background: Regulatory T cell (Treg) deficiency leads to IPEX syndrome, a lethal autoimmune disease, in Human and mice. Dysbiosis of the gut microbiota in Treg-deficient scurfy (SF) mice has been described, but to date, the role of the gut microbiota remains to be determined. Results: To examine how antibiotic-modified microbiota can inhibit Treg deficiency-induced lethal inflammation in SF mice, Treg-deficient SF mice were treated with three different antibiotics. Different antibiotics resulted in distinct microbiota and metabolome changes and led to varied efficacy in prolonging lifespan and reducing inflammation in the liver and lung. Moreover, antibiotics altered plasma levels of several cytokines, especially IL-6. By analyzing gut microbiota and metabolome, we determined the microbial and metabolomic signatures which were associated with the antibiotics. Remarkably, antibiotic treatments restored the levels of several primary and secondary bile acids, which significantly reduced IL-6 expression in RAW macrophages in vitro. IL-6 blockade prolonged lifespan and inhibited inflammation in the liver and lung. By using IL-6 knockout mice, we further identified that IL-6 deletion provided a significant portion of the protection against inflammation induced by Treg dysfunction. Conclusion: Our results show that three antibiotics differentially prolong survival and inhibit lethal inflammation in association with a microbiota-IL-6 axis. This pathway presents a potential avenue for treating Treg deficiency-mediated autoimmune disorders.
... Surprisingly, the lack of Foxp3 in scurfy mice results in multiorgan inflammatory conditions, but not colitis. 13,[16][17][18] This lack of colitis development may be due to the premature death of the mice at approximately 3 weeks of age. Sharma et al 19,20 found that the transfer of scurfy lymphocytes into adult Rag1 −/− mice causes colitis while transfer into Rag1 −/− neonates only causes colitis after weaning. ...
Full-text available
Recently, several studies have investigated a number of rare monogenic autoimmune disorders, in which the causative genetic defects were identified and found to affect the development or function of regulatory T cells (Tregs). The studies of these disorders have facilitated a deeper understanding of the mechanisms involved in immune regulation and tolerance. Furthermore, these studies have highlighted the importance of Tregs in maintaining homeostasis at the mucosal interface between the host and microbiome. Here, we offer our perspective on these monogenic autoimmune disorders, highlighting their overlapping clinical features with inflammatory bowel disease.
... To examine a requirement for Foxp3 + Treg cells in the oral mucosa, next, we analyzed scurfy mice, which are germline-deficient for Foxp3 (Foxp3 sf ) 2 . Scurfy mice display multiorgan failure due to systemic autoimmune reactions, as illustrated by heavy lymphocytic infiltrations into skin, lung, and LN (Supplementary Figure 3a) 2,22 . Curiously, autoimmune inflammation in the small intestine mucosa of scurfy mice is markedly reduced, indicating a tissue-specific reliance on Foxp3 + Treg cells for maintaining peripheral tolerance (Supplementary Figure 3b) 23 . ...
The oral mucosa is a critical barrier tissue that protects the oral cavity against invading pathogens and foreign antigens. Interestingly, inflammation in the oral cavity is rarely observed, indicating that overt immune activation in this site is actively suppressed. Whether Foxp3+ Treg cells are involved in controlling immunity of the oral mucosa, however, is not fully understood. Here, we show that the oral mucosa is highly enriched in Foxp3+ Treg cells, and that oral mucosa Treg cells are phenotypically distinct from those of LN or spleen, as they expressed copious amounts of the tissue-retention molecule CD103 and unusually high-levels of CTLA4. Acute depletion of Foxp3+ Treg cells had catastrophic effects, resulting in marked infiltration of activated effector T cells that were associated with autoimmunity and tissue destruction of the oral mucosa. Moreover, adoptive transfer of naive CD4 T cells revealed that the oral mucosa is highly ineffective in inducing Foxp3+ Treg cells in situ, so that it depends on recruitment and migration of exogenous Treg cells to populate this mucosal site. Collectively, these results demonstrate a previously unappreciated role and a distinct developmental pathway for Foxp3+ Treg cells in the oral mucosa, which are essential to control local tissue immunity.
... The first evidence to suggest a role for Pak2 in Treg function followed the observation that Pak2 F/F ;Foxp3-Cre mice developed a severe and lethal multi-organ lymphoproliferative disorder, similar to that observed in scurfy mice possessing a mutation in the Foxp3 allele 34,35 . In the absence of Pak2, Tregs showed a dramatic reduction in expression of several key functional molecules, including CD25, CTLA-4 and NRP-1, all of which have been implicated in regulating the suppressive capacity of Tregs [36][37][38] . ...
Full-text available
Foxp3, a key transcription factor that drives lineage differentiation of regulatory T cells (Tregs), was thought to imprint a unique and irreversible genetic signature within Tregs. Recent evidence, however, suggests that loss or attenuation of Foxp3 expression can cause Tregs to de-differentiate into effector T cells capable of producing proinflammatory cytokines. Herein, we report that the signaling kinase, p21-activated kinase 2 (Pak2), is essential for maintaining Treg stability and suppressive function. Loss of Pak2, specifically in Tregs, resulted in reduced expression of multiple Treg functional molecules, including Foxp3, CD25, Nrp-1 and CTLA-4, coupled with a loss of Treg suppressive function in vitro and in vivo. Interestingly, Pak2-deficient Tregs gained expression of Th2-associated cytokines and the transcription factor, Gata3, becoming Th2-like cells, explaining their inability to regulate immune responses. Collectively, these findings suggest Pak2 as an important signaling molecule for guarding against aberrant immune responses through regulating the stability of Foxp3+ Tregs and maintaining a suppressive Treg phenotype.
... 6,9,10 Forkhead box P3 (Foxp3)-expressing regulatory T cells (Tregs) are anti-inflammatory cells. [11][12][13][14][15] Depletion of Tregs worsens IRI, whereas supplementation of Tregs is protective. [16][17][18] Although autologous Tregs provide a transformative approach to therapy, obtaining sufficient numbers of ex vivo expanded Tregs remains a significant problem. ...
CD4(+)Foxp3(+) regulatory T cells (Tregs) protect the kidney during AKI. We previously found that IL-2, which is critical for Treg homeostasis, upregulates the IL-33 receptor (ST2) on CD4(+) T cells, thus we hypothesized that IL-2 and IL-33 cooperate to enhance Treg function. We found that a major subset of Tregs in mice express ST2, and coinjection of IL-2 and IL-33 increased the number of Tregs in lymphoid organs and protected mice from ischemia-reperfusion injury (IRI) more efficiently than either cytokine alone. Accordingly, we generated a novel hybrid cytokine (IL233) bearing the activities of IL-2 and IL-33 for efficient targeting to Tregs. IL233 treatment increased the number of Tregs in blood and spleen and prevented IRI more efficiently than a mixture of IL-2 and IL-33. Injection of IL233 also increased the numbers of Tregs in renal compartments. Moreover, IL233-treated mice had fewer splenic Tregs and more Tregs in kidneys after IRI. In vitro, splenic Tregs from IL233-treated mice suppressed CD4(+) T cell proliferation better than Tregs from saline-treated controls. IL233 treatment also improved the ability of isolated Tregs to inhibit IRI in adoptive transfer experiments and protected mice from cisplatin- and doxorubicin-induced nephrotoxic injury. Finally, treatment with IL233 increased the proportion of ST2-bearing innate lymphoid cells (ILC2) in blood and kidneys, and adoptive transfer of ILC2 also protected mice from IRI. Thus, the novel IL233 hybrid cytokine, which utilizes the cooperation of IL-2 and IL-33 to enhance Treg- and ILC2-mediated protection from AKI, bears strong therapeutic potential.
... To determine whether NRF2 activation exerts Treg-independent suppression of autoimmune-mediated inflammation, we used scurfy (Sf) mice, which possess a missense mutation in the Foxp3 gene on the X chromosome (21). Because the development and maintenance of Tregs largely depend on the transcription factor FOXP3 (22,23), Sf mice are almost completely deficient in functional Tregs and thereby develop severe multiorgan inflammation with hyperactivation of autoreactive effector T cells, which results in lethality by 4 weeks of age (24). Thus, we used Sf mice to investigate the Treg-independent suppressive effects of NRF2 on the activation status of inflammatory cells, especially effector T cells. ...
Full-text available
The transcription factor NRF2 (nuclear factor (erythroid-derived 2)-like 2) plays crucial roles in the defense mechanisms against oxidative stress and mediates anti-inflammatory actions in various pathological conditions. Recent studies have shown that the dysfunction of regulatory T cells (Tregs) is directly linked to the initiation and progression of various autoimmune diseases. To determine the Treg-independent impact of NRF2 activation on autoimmune inflammation, we examined Scurfy (Sf) mice that are deficient in Tregs and succumb to severe multi-organ inflammation by 4 weeks of age. We found that systemic activation of NRF2 by Keap1 (kelch-like ECH-associated protein 1) knockdown ameliorated tissue inflammation and lethality in Sf mice. Activated T cells and their cytokine production were accordingly decreased by Keap1 knockdown. In contrast, NRF2 activation through cell lineage-specific Keap1 disruption (i.e ., in T cells, myeloid cells or dendritic cells) only achieved partial or no improvement in the inflammatory status of Sf mice. Our results indicate that systemic activation of NRF2 suppresses effector T-cell activities independently of Tregs and that NRF2 activation in multiple cell lineages appears to be required for sufficient anti-inflammatory effects. This study emphasizes the possible therapeutic application of NRF2 inducers in autoimmune diseases that are accompanied by Treg dysfunction.
... This information is critically important for the design of clinical protocols that will either expand preexisting tTregs or accelerate de novo conversion to pTregs. Because mice with impaired tTregs development suffer from multiorgan autoimmunity [6][7][8], whereas aged, pTreg-deficient mice develop allergic inflammation in the small intestine and have increased rates of preeclampsia [9,10], Tregs of different origin may play non-redundant roles in controlling autoimmunity [4]. It has also been proposed that tTregs control tolerance to self-antigens because their differentiation in the thymus is guided by TCRs that recognize self-antigens with relatively high affinities [11,12]. ...
Full-text available
Helios transcription factor and semaphorin receptor Nrp-1 were originally described as constitutively expressed at high levels on CD4+Foxp3+ T regulatory cells of intrathymic origin (tTregs). On the other hand, CD4+Foxp3+ Tregs generated in the periphery (pTregs) or induced ex vivo (iTregs) were reported to express low levels of Helios and Nrp-1. Soon afterwards the reliability of Nrp-1 and Helios as markers discriminating between tTregs and pTregs was questioned and until now no consensus has been reached. Here, we used several genetically modified mouse strains that favor pTregs or tTregs formation and analyzed the TCR repertoire of these cells. We found that Tregs with variable levels of Nrp-1 and Helios were abundant in mice with compromised ability to support natural differentiation of tTregs or pTregs. We also report that TCR repertoires of Treg clones expressing high or low levels of Nrp-1 or Helios are similar and more alike repertoire of CD4+Foxp3+ than repertoire of CD4+Foxp3- thymocytes. These results show that high vs. low expression of Nrp-1 or Helios does not unequivocally identify Treg clones of thymic or peripheral origin.
Akt isoforms play key roles in multiple cellular processes; however, the roles of Akt-1 and Akt-2 isoforms in the development of T cell-mediated autoimmunity are poorly defined. In this study, we showed that Akt1-/- mice develop ameliorated experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, whereas Akt2-/- mice develop exacerbated EAE, compared with wild-type mice. At the cellular level, Akt-1 appears to inhibit proliferation of thymus-derived regulatory T cells (tTregs), which facilitates Ag-specific Th1/Th17 responses. In a sharp contrast to Akt-1, Akt-2 potentiates tTreg proliferation in vitro and in vivo and suppresses Ag-specific Th1/Th17 responses. Furthermore, treating mice with established EAE with a specific Akt-1 inhibitor suppressed disease progression. Our data demonstrate that Akt-1 and Akt-2 differentially regulate the susceptibility of mice to EAE by controlling tTreg proliferation. Our data also indicate that targeting Akt-1 is a potential therapeutic approach for multiple sclerosis in humans.
Full-text available
We have examined the extent of allelic exclusion at the T cell receptor (TCR) beta locus using monoclonal antibodies specific for V beta products. A small proportion (approximately 1%) of human peripheral blood T cells express two V beta as determined by flow cytometric analysis, isolation of representative clones, and sequencing of the corresponding V beta chains. Dual beta T cells are present in both the CD45R0+ and CD45R0- subset. These results indicate that dual beta expression is compatible with both central and peripheral selection. They also suggest that the substantial degree of TCR beta allelic exclusion is dependent only on asynchronous rearrangements at the beta locus, whereas the role of the pre-TCR is limited to signaling the presence of at least one functional beta protein.
Full-text available
We have previously reported that a subset of T cells in T cell receptor (TCR)-transgenic mice may express two different α chains on their surface. The expression of two functional α chains has also been demonstrated for human peripheral blood T cells. In this report, we show that a proportion of normal murine lymph node T cells express two functional α chains on their surface. The extrapolated frequency of these cells present in the normal repertoire ranges from 7–21%, with an average of 15%. Our analysis of a small number of antigen-specific T cell clones suggests that the frequency of antigen-responsive cells expressing two surface α chains is relatively low. This raises the possibility that dual α chain T cells may have a selective disadvantage in responding to specific antigen.
Full-text available
Scurfy (Sf) mice bear a mutation in the Foxp3 transcription factor, lack regulatory T cells (Treg), develop multiorgan inflammation, and die prematurely. The major target organs affected are skin, lungs, and liver. “Sf mice lacking the Il2 gene (Sf.Il2–/–), despite being devoid of Treg, did not develop skin and lung inflammation, but the inflammation in liver remained [corrected]. Genome-wide microarray analysis revealed hundreds of genes that were differentially regulated among Sf, Sf.Il2(-/-), and B6 CD4(+) T cells, but the most significant changes were those encoding receptors for trafficking/chemotaxis/retention and cytokines. Our study suggests that IL-2 controls the skin and lung inflammation in Sf mice in an apparent "organ-specific" manner through two novel mechanisms: by regulating the expression of genes encoding a variety of receptors for T cell trafficking/chemotaxis/retention and by regulating Th2 cell expansion and cytokine production. Thus, IL-2 is potentially a master regulator for multiorgan inflammation and an underlying etiological factor for various diseases associated with skin and lung inflammation.
Full-text available
Scurfy mice have a deletion in the Foxp3 gene, resulting in a failure to generate Foxp3(+) regulatory T cells, and they subsequently develop severe CD4(+) T-cell-mediated autoimmune inflammation. Multiple organs are involved, but the skin is one of the main organs affected. During the course of disease, Scurfy mice develop autoantibodies; however, the targeted antigens are unknown. In this study, we show that Scurfy mice develop autoantibodies directed against skin antigens. Using western blot analysis, we found that Scurfy serum reacted with proteins in total skin lysate, as well as in a keratinocyte lysate. Most of the Scurfy sera tested identified a major band at 50 kDa. Transfer of Scurfy CD4(+) T cells into nu/nu mice yielded autoantibodies with similar reactivity. Further analysis using 2D western blots, followed by peptide mass fingerprinting, identified several keratins as targets. To confirm this observation, we chose one of the identified targets, keratin 14, and prepared recombinant proteins encompassing the N-terminal, middle, and C-terminal portions of the keratin 14 protein. Scurfy serum predominantly recognized the C-terminal fragment. Sera from patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, the human disease resulting from FOXP3 mutations, also recognized skin antigens, including keratin 14. Thus, the results of our study indicate that autoantibodies in Scurfy mice and patients with IPEX target keratins.
Full-text available
Foxp3(+) regulatory T cells (Tregs) are crucial for preventing autoimmunity. We have demonstrated that depletion of Foxp3(+) Tregs results in the development of a scurfy-like disease, indicating that Foxp3(-) effector T cells are sufficient to induce autoimmunity. It has been postulated that nonfunctional Tregs carrying potentially self-reactive T cell receptors may contribute to scurfy (sf) pathogenesis due to enhanced recognition of self. Those cells, however, could not be identified in sf mutants due to the lack of Foxp3 protein expression. To address this issue, we crossed the natural sf mouse mutant with bacterial artificial chromosome transgenic DEREG (depletion of regulatory T cells) mice. Since DEREG mice express GFP under the control of an additional Foxp3 promoter, those crossings allowed proving the existence of "would-be" Tregs, which are characterized by GFP expression in the absence of functional Foxp3. Sf Tregs lost their in vitro suppressive capacity. This correlated with a substantial reduction of intracellular cAMP levels, whereas surface expression of Treg markers was unaffected. Both GFP(+) and GFP(-) sf cells produced high amounts of Th2-type cytokines, reflected also by enhanced Gata-3 expression, when tested in vitro. Nevertheless, sf Tregs could be induced in vitro, although with lower efficiency than DEREG Tregs. Transfer of GFP(+) sf Tregs, in contrast to GFP(-) sf T cells, into RAG1-deficient animals did not cause the sf phenotype. Taken together, natural and induced Tregs develop in the absence of Foxp3 in sf mice, which lack both suppressive activity and autoreactive potential, but rather display a Th2-biased phenotype.
Full-text available
Homeostasis in the immune system is maintained by specialized regulatory CD4(+) T cells (T(reg)) expressing transcription factor Foxp3. According to the current paradigm, high-affinity interactions between TCRs and class II MHC-peptide complexes in thymus "instruct" developing thymocytes to up-regulate Foxp3 and become T(reg) cells. However, the loss or down-regulation of Foxp3 does not disrupt the development of T(reg) cells but abrogates their suppressor function. In this study, we show that Foxp3-deficient T(reg) cells in scurfy mice harboring a null mutation of the Foxp3 gene retained cellular features of T(reg) cells including in vitro anergy, impaired production of inflammatory cytokines, and dependence on exogenous IL-2 for proliferation and homeostatic expansion. Foxp3-deficient T(reg) cells expressed a low level of activation markers, did not expand relative to other CD4(+) T cells, and produced IL-4 and immunomodulatory cytokines IL-10 and TGF-beta when stimulated. Global gene expression profiling revealed significant similarities between T(reg) cells expressing and lacking Foxp3. These results argue that Foxp3 deficiency alone does not convert T(reg) cells into conventional effector CD4(+) T cells but rather these cells constitute a distinct cell subset with unique features.
Full-text available
Scurfy (Foxp3(Sf)/Y), Il2(-/-), and Il2ralpha(-/-) mice are deficient in CD4(+)Foxp3(+) regulatory T cells (Treg), but only the latter two develop inflammation in the submandibular gland (SMG), a critical target of Sjögren's syndrome. In this study, we investigated the reason that SMG of Scurfy (Sf), Sf.Il2(-/-), Sf.Il2ralpha(-/-), and the long-lived Sf.Fas(lpr/lpr) mice remained free of inflammation, even though their lymph node cells induced SMG inflammation in Rag1(-/-) recipients. A strong correlation was observed between the development of the granular convoluted tubules (GCT) of the SMG in these mice and SMG resistance to inflammation. Moreover, GCT development in Sf.Rag1(-/-) mice was not impeded, indicating a role of adaptive immunity. In the Sf.Fas(lpr/lpr) mice, this block was linked to atrophy and inflammation in the accessory reproductive organs. Testosterone treatment restored GCT expression, but did not induce SMG inflammation, indicating GCT is not required for inflammation and additional mechanisms were controlling SMG inflammation. Conversely, oral application of LPS induced SMG inflammation, but not GCT expression. LPS treatment induced up-regulation of several chemokines in SMG with little effect on the chemokine receptors on CD4(+) T cells in Sf mice. Our study demonstrates that Sf mutation affects SMG development through adaptive immunity against accessory reproductive organs, and the manifestation of SMG inflammation in Sf mice is critically controlled through innate immunity.
Interferon-gamma (IFN-gamma) exerts pleiotropic effects, including antiviral activity, stimulation of macrophages and natural killer cells, and increased expression of major histocompatibility complex antigens. Mice without the IFN-gamma receptor had no overt anomalies, and their immune system appeared to develop normally. However, mutant mice had a defective natural resistance, they had increased susceptibility to infection by Listeria monocytogenes and vaccinia virus despite normal cytotoxic and T helper cell responses. Immunoglobulin isotype analysis revealed that IFN-gamma is necessary for a normal antigen-specific immunoglobulin G2a response. These mutant mice offer the possibility for the further elucidation of IFN-gamma-mediated functions by transgenic cell- or tissue-specific reconstitution of a functional receptor.
T helper 17 (Th17) cells are important for host defense against extracellular microorganisms. However, they are also implicated in autoimmune and chronic inflammatory diseases, and as such need to be tightly regulated. The mechanisms that directly control committed pathogenic Th17 cells in vivo remain unclear. We showed here that IL-17A-producing CD4 + T cells expressed interleukin-10 receptor a (IL-10Ra) in vivo. Importantly, T cell-specific blockade of IL-10 signaling led to a selective increase of IL-17A + IFN-g À (Th17) and IL-17A + IFN-g + (Th17+Th1) CD4 + T cells during intestinal inflamma-tion in the small intestine. CD4 + Foxp3 À IL-10-pro-ducing (Tr1) cells and CD4 + Foxp3 + regulatory (Treg) cells were able to control Th17 and Th17+Th1 cells in an IL-10-dependent manner in vivo. Lastly, IL-10 treatment of mice with established colitis decreased Th17 and Th17+Th1 cell frequencies via direct signaling in T cells. Thus, IL-10 signaling directly suppresses Th17 and Th17+Th1 cells.
The Foxp3(+)CD4(+) regulatory T-cell (Treg)-deficient Scurfy (Sf) mice rapidly develop severe inflammation in the skin and lungs with expanded Th subsets bearing increased expression of various chemokine/chemoattractant/retention receptor genes (CRG). Nine different double mutants were generated to elucidate their roles in the skin and lung inflammation. The expanded Th2 response and the increased expression of several CRG for the skin and lung inflammation were inhibited in Sf.Il2(-/-) mice as previously described using microarray analysis. Herein in a reciprocal approach, we demonstrated that Sf.Il4(-/-) and Sf.Stat6(-/-) mice, despite lacking Th2 cytokines IL-4, IL-5, and IL-13, as well as the IL-4/STAT6-dependent CRG expression, the inflammation in the skin and lungs remained. The effect of the other Th1 cytokine IFN-γ was studied in Sf.Ifng(-/-) mice in which the multi-organ inflammation (MOI) was delayed but fully developed afterward with enhanced CRG expression except for the IFN-γ-dependent Cxcr3 in CD4(+) T-cells. Similarly, a transient delay of MOI was observed for Sf.Itgae(-/-) mice but their Th subsets and the critical CRG expansion remained. Ltb4r1(-/-), Alox5(-/-), Cx3cr1(gfp/gfp), or Il10(-/-) mutant genes also failed to effectively block inflammation in the skin and lungs in Sf mice. Our study has identified a novel function of IL-2 as a powerful Th1 cytokine that induces a panel of CRG in Th subsets required for skin and lung inflammation in Sf mice. The CRG panel induced by IL-2 but not by IL-4 or IFN-γ explains the apparent "organ-specific" display of the skin and lung inflammation in Sf mice.